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INTRODUCTION
Chronic postoperative pain
The first publication that identified surgery as major risk factor for chronic pain appeared in 
1998 gaining increasing interest since. 1 Chronic postoperative pain (CPP) is experienced by 
5 to 50% of patients after various common operations of which 5% experience CPP of severe 
intensity. This is a significant number when the huge number of operations conducted is 
considered. 2,3 CPP leads to disability, repeated clinical encounters, consultations with an-
esthesiologists and other specialists, additional imaging studies, and extra costs in various 
ways. Hence the consequences of CPP are significant, not only in terms of a reduced quality 
of life for the individual patient but also with regard to the burden to health care and social 
and economic support systems. 4 
Pain is defined by the International Association for the Study of Pain (IASP) as an unpleas-
ant sensory and emotional experience associated with actual or potential tissue damage, or 
described in terms of such damage.5 CPP is normally considered to be pain that persists or 
keeps coming back for more than three months postoperatively or exceeding the expected 
healing time. Other causes for CPP such as infection or cancer have to be ruled out and CPP 
is not pain continuing from the original condition. 5
The pathophysiological concept of CPP remains difficult to determine. It was initially thought 
to be primarily neuropathic, but ongoing nociception might also play a role according to 
neurophysiological assessments. 6 There is often no precise demarcation between nociceptive 
and neuropathic pain and diagnosis is complicated by the influence of social, genetic and psy-
chological factors.7 According to the Committee of the International Association for the Study 
of Pain (IASP) neuropathic pain arises after injury to nerves or sensory transmitting systems in 
the spinal cord and brain. A key feature of this type of pain is the combination of sensory loss 
(negative phenomena) and spontaneous paradoxical hypersensitivity (positive phenomena) 
located within and beyond the damaged nerve innervation territory. The hypersensitivity can 
mask the sensory loss and is often burning, sharp or stabbing in character. Neuropathic CPP 
may arise direct postoperatively and then persist in the absence of any peripheral noxious 
stimulus or ongoing peripheral inflammation. Infrequently neuropathic CPP arises months to 
years after the operation. Nociceptive CPP results from activation of nociceptors of peripheral 
sensory neurons by inflammatory mediators. For example, this might be due to a continuous 
inflammatory reaction around foreign material like the mesh used to repair inguinal hernia. 
This may also lead to subsequent inflammatory nerve damage inflicting neuropathic CPP. 8,9 
Nociceptive pain is often more difficult to describe. It is mostly characterized as aching, gnaw-
ing or pulling without abnormal cutaneous sensations.
Given that only subsets of surgical patients develop CPP, there may be factors that pre-
dispose an individual to develop CPP. These predictive factors are usually divided in patient-
specific and surgery-specific factors and subdivided into preoperative, intra-operative, and 
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postoperative factors. 3,10 Important patient related factors are moderate to severe preopera-
tive pain lasting more than one month, psychological vulnerability, female gender, younger 
age and genetic predisposition. Thereafter the overall severity (not maximum severity) of 
pain over the first seven days after surgery plays a role. However, particularly with regard 
to this risk factor, it is very difficult to differentiate between causality and association.3,11 Of 
the surgery specific factors, the surgical approach, the surgical technique and the duration 
of the operation seem to be important: operations that reduce nerve injury, like minimal 
invasive procedures, seem to be superior. 3,10
The problem of CPP is not limited to major surgery as it is even the most common and 
serious long-term complication after inguinal hernia repair, a relatively minor operation, to-
gether with laparotomy representing the commonest operations performed worldwide. 12
Chronic pain after laparotomy
The burden of adhesions
Adhesions result from fibrin exudates that follow any kind of trauma to the parietal perito-
neum caused by inflammation or surgery. These fibrin exudates form temporary adhesions 
until the fibrinolytic system absorbs the fibrin. Absorption is delayed in the presence of 
ischemia, inflammation or foreign bodies like meshes which are probably the most common 
biomaterials implanted in surgical medicine. In these conditions adhesions can mature and 
remain. Postoperative adhesion formation is the most common complication of abdominal 
and pelvic surgery and comprise a lifelong risk for various clinical entities like small bowel ob-
struction, infertility and complications during subsequent surgery.13 Whether adhesions can 
also be held responsible for CPP remains a subject of debate although nerve fibers are found 
frequently (78%–100%) in intra-abdominal adhesions. Thereafter adhesions are thought to 
cause pain indirectly by restricting organ motion. However most patients with postoperative 
intra-abdominal adhesions are asymptomatic. This was illustrated by the findings of Ditzes et 
al who found no more CPP in patient operated because of complicated appendicitis com-
pared to uncomplicated appendicitis which elicits less adhesions formation. 14
In literature the exact prevalence of CPP after laparotomy varies. One study reported a 
prevalence of 18% in patients four years after laparotomy for gastrointestinal malignant or 
non-malignant conditions. Another study reported an incidence of 40% in patients after 
laparotomy for small bowel obstruction.15 These patients experience a significant reduced 
QOL which is independent of cancer status.2 In 35-50% of patients with CPP, in which di-
agnostic tools have been exhausted, the only pathological findings are adhesions found 
at laparoscopy. Whether these patients will benefit from laparoscopic adhesiolysis is still 
subject of discussion and the procedure has its own significant morbidity because of iatro-
genic enterotomy. Thereafter CPP frequently recurs which can be explained by reformation 
of adhesions, increased severity of adhesions and the novo adhesion formation. Thereafter 
it should be realized that unexplained CPP can be part of centrally mediated disorders of 
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1gastrointestinal pain, formerly known as functional abdominal pain syndrome. This refl ects a range of gastrointestinal symptoms believed to have a central origin, where central dys-
regulation of pain is the major contributor. Among this is the centrally mediated abdominal 
pain syndrome (CAPS) resulting from central sensitization with disinhibition of pain signals 
rather than increased peripheral aff erent excitability. Characteristics are the expression pain 
of varying intensity, urgent reporting of intense symptoms, minimizing a potential role for 
psychosocial contributors, frequently seeking for health care, request for narcotic analgesics, 
focusing attention on complete symptom relief, taking limited personal responsibility for 
self-management, and requesting diagnostic studies. These are characteristics comparable 
with the patient population presenting with CPP. CAPS / CPP management relies on a strong 
patient-physician relationship, early incorporation of non-pharmacological therapies, and 
referral for behavioral health therapies when needed.16 
Chronic pain after inguinal hernia surgery
The inguinal hernia
The word ‘hernia’ is derived from the Greek word kele/hernios which means bud or off shoot. 
A hernia is a protrusion of parietal peritoneum, the ‘peritoneal sac’, through a preformed or 
secondarily established defect in the abdominal wall. Inguinal (groin) hernia is a common 
condition with an incidence of 6 to 12 per cent in adult males and increasing with age 
reaching 22.8% in persons aged 60-74 year. 17 It aff ects men more often than women. The 
natural course of inguinal hernias is usually slow, but they can reach impressive sizes (Figure 
1). Important intrinsic risk factors for the development of primary inguinal hernia include: in-
Figure 1. A man with a 69 years history of inguinal 
hernia. The patient, Frank Lamb, was a slave in North 
Carolina and since he was 9 years old suff ered from 
left inguinal hernia. Nevertheless he was forced to 
hard, daily labor. As a result an important scrotal 
hernia developed. From: Otis Historical Archives of 
“National Museum of Health and Medicine”.
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heritance, a previous contralateral hernia, gender, age and abnormal collagen metabolism. 
Important acquired risk factors are prostatectomy and obesity. Since there is a low com-
plication risk (incarceration or strangulation) in asymptomatic or minimally symptomatic 
men watchful waiting for minimal or asymptomatic inguinal hernias is safe. However the 
crossover rate to surgery is high due to the development of complaints or pain.
The history of hernia surgery
Hernias and their treatment were already described by the The Egyptians (1500 BC), Phoeni-
cians (900 BC) and Ancient Greeks (400 BC). 18 Various non-surgical treatments were described 
including bloodletting, tobacco enemas, herbal dressings, special diets and compression 
devices or inguinal belts that were supposed to maintain the hernia sac inside the body 
cavity as they are still used today. 19 Surgical techniques were restricted to inguinal hernias 
complicated by incarceration or strangulation. They consisted of cauterization causing a 
stricturing scar like a permanent groin belt (Figure 2) or wide excision of the sac with sur-
rounding skin and all its contents including hemicastration because of the spermatic duct 
running close to or stucked to the hernia sac. During the operation incarcerated patients 
were positioned upside down to facilitate reduction of the hernia (Figure 3). These surgical 
techniques carried a high risk of permanent stoma or death from bleeding, peritonitis and 
infection. 20,21 Operations were only done to save lives and not to reduce groin discomfort. 
Hence recurrence rates were not given a second thought, as immediate survival was the 
surgeons’ major preoccupation. 22
It was not until the mid-1700s, the so called Age of Dissection, when there became an 
understanding of the inguinal anatomy and the nature of hernia development leading to 
the fi rst major steps in fi nding a solution to the problem. 18 Important anatomical structures 
were identifi ed and named after the anatomists or surgeons: Gimbernat’s ligament (1793), 
the transverse fascia and Cooper’s ligament (1804), Poupart’s Ligament, Hasselbach’s tri-
angle, and the iliopubic tract (1814). 20,22 
Figure 2. Cautorisation of inguinal hernia by the 
Arabics in the 12th century
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Edoardo Bassini (1844-1924) was an Italian surgeon who was the fi rst to realize that the 
problem was more within the diseased anatomy and physiology of the inguinal canal than 
in the surgical technique itself: „In order to achieve a radical cure of hernia it is absolutely 
essential to restore those conditions in the area of the hernial orifi ce, which exist under 
normal conditions”. [27,28] 
This understanding together with the recent anatomical knowledge led to the introduc-
tion in 1884 of the fi rst durable inguinal hernia repair technique in which the inguinal fl oor 
was completely reconstructed. After complete incision of the fascia transversals, a triple 
layer consigned of fascia transversalis, aponeurosis of the musculus transversus abdominis 
and musculus obliquus internus (conjoint tendon), was sutured to the inguinal ligament 
(Poupart). This technique was long time the golden standard for inguinal hernia surgery 
in Europe. Other suture techniques were designed by the Canadian surgeon Shouldice 
(1890-1965) and the American surgeon McVay of which the latter popularized his concept 
of inguinal hernia repair using Cooper’s ligament instead of the inguinal ligament.[29]
In the nineteen century various techniques using woven soft metal grafts as a reinforce-
ment material (mesh) were used and found to be unsatisfactory. In1935 Wallace Carothers, 
a chemist at Dupont, discovered a method to create synthetic polymers and he is credited 
with the creation of nylon. The “era of plastics” was ushered leading to the introduction of 
polyester and polypropylene meshes. Initially the mesh was used to reinforce the posterior 
wall of the inguinal canal after performing a standard repair as in „tense” repairs hereby 
reducing recurrence rates. Until 1984 when Irvin Lichtenstein announced: „There is evidence 
Figure 3. Resection of an inguinal hernia in
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that to incise a strong posterior layer and, then, to reconstruct it as in the Bassini, Shouldice 
or McVay repair is inappropriate, disruptive and even meddlesome. The application of a 
wide sheet of harmless prosthetic mesh, one which serves only to strengthen such a floor, 
is harmless and should reduce the incidence of recurrences”.[30] He, or more precisely his 
colleague Alex Shulman, introduced a “tension free” mesh repair. This technique has become 
the gold standard in open tension free hernioplasties due to its effectiveness, easiness to 
perform, safety and low rate of complications and recurrences. Furthermore it can be per-
formed under local anesthesia in a day care setting.
The first laparoscopic inguinal hernia repair was described in 1979 and in1989 a prosthetic 
mesh was introduced during laparoscopic hernia repair. Various laparoscopic techniques 
were developed of which the TAPP (transabdominal pre-peritoneal) and TEP (totally extra-
peritoneal) have become the most common techniques used today.
Prosthetic meshes have revolutionized hernia surgery because rates of recurrence and 
chronic postoperative inguinal pain (CPIP) are significantly lower than in autologous repair. 
This is thought to be related to the ability to use a tension free technique rather than the 
mesh itself. However the downside of CPIP remains. The reported frequency of CPIP after 
Lichtenstein repair varies widely because of different definitions used. In 2000, Poobalan 
et al reviewed the literature of CPIP and found incidences ranging from 0% to 63%. 23 A 
similar range was reported by Aasvang and Kehlet in an update. 8 The overall incidence of 
moderate to severe CPIP that interferes with daily living is estimated to be around 10–12%. 
24 Debilitating CPIP affecting normal daily activities or work ranges from 0.5 to 6%. 9 This is 
largely exceeding the incidence of recurrence making CPIP the most important complica-
tion of inguinal hernia repair today. Regarding the high number of repairs, the incidence 
of 11% and the fact that CPIP is especially effecting young otherwise healthy males, CPIP 
must be considered a major health problem with significant socio-economic impact. 25,26 
Improvements in clinical outcome therefore have great medical and economic impact.
Patients with CPIP commonly experience both nociceptive and neuropathic pain. For 
neuropathic pain to occur one of the four nerves that cover the sensory innervation of the 
inguinal region and lower abdomen have to be damaged during hernia repair. When the 
inguinal region is approached anteriorly three nerves are at risk: the iliohypogastric nerve 
which supplies the region cranially to the pubic tubercle and more laterally to the hip re-
gion, the ilioinguinal nerve covering sensation to the base of the pubic area and inner thigh, 
the genital branch of the genitofemoral nerve innervating the scrotum or labia majora. The 
lateral femoral cutaneous nerve is rarely affected during Lichtenstein repair because of its 
lateral position, but can be damaged when tackers are used to fixate the mesh during TEP 
repair. The pain can often be intensified by stretching of the hip joint, coughing, sneez-
ing, sexual intercourse and tension of the abdominal muscles causing nerve traction or 
compression.9,27 Nerves can be damaged due to dissection during operation, entrapment 
by the mesh and sutures to secure the mesh and postoperative complications like inflam-
17
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1mation (periostitis, foreign body reaction to mesh or sutures). Neuropathic pain can be felt in or around the inguinal scar and radiating into the skin area innervated by the damaged 
nerve. Nociceptive pain can often be aggregated by applying pressure to the mesh and 
can develop after some months because of mechanical pressure by mesh displacement or 
contraction.
Recently new mesh products have been developed which offer the potential to decrease 
CPIP. In this research a semi-resorbable self-fixing mesh is investigated. It is presumed that 
the self-fixing properties minimize entrapment neuropathy by omitting sutures or tackers. 
In addition the light weight construction of the mesh is known to reduce the amount of 
foreign body reaction thereby minimizing inflammatory damage to the surrounding tissue 
and nerves.
AIM OF THE THESIS 
The first part of the thesis addresses CPP after laparotomy judged to be caused by adhe-
sions. It aims to assess long term results of laparoscopic adhesiolysis as a treatment for 
CPP. The second part of the thesis addresses CPP after inguinal hernia repair (CPIP). It aims 
to determine whether a self-gripping mesh for open inguinal hernia repair according to 
Lichtenstein influences the incidence of CPIP. The third part focuses on the methodological 
quality and comparability of studies addressing CPIP after Lichtenstein hernioplasty. It aims 
to assess whether study outcomes are valid and can be compared to each other to make 
firm conclusions about the best treatment or prevention method for CPIP.
OUTlINE OF THE THESIS
In the first part of the thesis CPP judged to be caused by adhesions will be addressed
In Chapter 2 the long term follow up of a randomized controlled trial comparing lapa-
roscopic adhesiolysis and laparoscopy alone in patients with CPP after abdominal surgery 
will be evaluated.
In the second part studies are presented to evaluate a self-gripping mesh for Lichtenstein 
repair of primary inguinal hernias in adult patients.
In Chapter 3 and 4 the results of a long term follow-up retrospective study (Chapter 3) 
and a multi-center randomized controlled double blinded trial (Chapter 4) comparing a 
self-gripping mesh and a sutured mesh for Lichtenstein hernioplasty will be presented. It is 
hypothesized that a self-gripping mesh not needing traumatic fixating devices will reduce 
the incidence of CPIP, because there is less risk of nerve entrapment (neuropathic pain) or 
muscle and periosteal damage (nociceptive pain) by the sutures. This effect is supposed to 
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be enhanced by the macroporous lightweight structure of the mesh thereby reducing the 
foreign body reaction which may cause inflammatory damage to surrounding nerve and 
muscle fibers causing nociceptive and neuropathic pain.
In Chapter 5 the effect of a self-gripping mesh is further investigated in a meta-analysis 
of published randomized controlled trials comparing the self-gripping mesh with a sutured 
mesh for the Lichtenstein hernioplasty. While a number of meta-analysis on this subject 
have already been published this meta-analysis is thought to be of value because at this 
time new studies with larger populations and longer follow-up periods can be included 
which is essential for judging effects on CPIP.
The self-gripping mesh has micro hooks made of polylactic acid (PLA) on its lower surface 
which ensure tissue gripping of the mesh. Chapter 6 will report the influence of these PLA 
micro hooks on the biocompatibility of the mesh by using a proved in vitro model of human 
derived macrophages.
In the third part the quality and comparability of the literature on CPIP is reported
In Chapter 7 the uniformity and quality of studies addressing CPIP after Lichtenstein 
hernioplasty will be reviewed. It will be questioned whether there is uniformity in collecting 
data, definition of the outcome parameter CPIP and method of presenting outcomes.
Chapter 8 and 9 will summarize and discuss the conclusions of this thesis and Chapter 
10 will provide future perspectives.
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AbSTRACT
Objective
To evaluate long term effects of laparoscopic adhesiolysis for treating chronic abdominal 
pain.
Background
Laparoscopic adhesiolysis as a therapy for chronic pain is still controversial and long term 
effects are not known.
Methods
One hundred patients with abdominal pain attributed to adhesions were randomized to 
laparoscopic adhesiolysis or a placebo group with laparoscopy alone. Pain relief was as-
sessed after 12-year follow-up.
Results
Seventy-three percent fulfilled the long term follow up. Compared to the placebo group 
(n=31), patients in the adhesiolysis group (n=42) were significantly less often pain free (8 
versus 13, P=0.033, RR=1.3). This caused the adhesiolysis group to have a higher intake of 
analgesics (26 versus 16, P=0.379, RR 1.2, 95% CI 0.8-1.8), seek of medical consultants (14 
versus 6, P=0.186, RR1.33, 95% CI 0.9-1.9) and rate of additional surgery (8 against 1, P=0.042, 
RR=1.67, 95% CI 1.208-2.318). Both groups continued to have improved pain and quality of 
life scores.
Conclusion
This is the first long term placebo controlled trial regarding the use of laparoscopic adhe-
siolysis for treating chronic abdominal pain. Laparoscopic adhesiolysis was less beneficial 
than laparoscopy alone in the long term. Secondly, there was a powerful and long lasting 
placebo effect of laparoscopy. Since adhesiolysis is associated with an increased risk at surgi-
cal complications, avoiding this treatment will result in less morbidity and health care costs.
27
Laparoscopic adhesiolysis
2
INTRODUCTION
Attempts to determine the cause of chronic abdominal pain are often challenging. Intra-
abdominal adhesions seems to be the cause in 35% to 50% of patients.1 Whether these 
patients would benefit from laparoscopic adhesiolysis is a topic of discussion since success 
rates in literature range between 38% - 87%. 2 This was reason to perform a randomized 
double-blind placebo controlled trial regarding the use of laparoscopic adhesiolysis for 
treating patients with chronic abdominal pain attributed to adhesions. Patients were ran-
domized to either laparoscopic adhesiolysis (n=52) or laparoscopy alone (placebo group, 
n=48). The treatment arms were revealed to them at one year. At that time patients in the 
placebo group could request to have laparoscopic adhesiolysis. The 1-year results were 
published in The Lancet in 2003 and showed no benefit for the adhesiolysis group over the 
placebo (laparoscopy alone) group. 3 The outcomes after 12 years of follow-up are reported 
here.
METHODS
Study design
This multi-center randomized controlled trial, included patients with chronic abdominal 
pain likely to be caused by adhesions from previous abdominal surgery. Chronic abdominal 
pain was defined as continues or intermittent abdominal pain of at least six months’ dura-
tion. After excluding other pathology (see exclusion criteria) included patients underwent a 
diagnostic laparoscopy to confirm the adhesions and to exclude serious morbidity not vis-
ible with other diagnostics. If during laparoscopy adhesions were the only pathology pres-
ent, patients were randomly assigned either to laparoscopic adhesiolysis or no treatment. 
For the randomization and surgical procedures we refer to the original article.3 Patients were 
unaware of their treatment assignment and the outcome assessment was blinded. Abdomi-
nal pain and quality of life (QOL) were assessed pre-operatively and at 3, 6 and 12 months 
of follow-using a visual analog scale (VAS), verbal rating pain change score (VRCS) and the 
short form 36 (SF-36). After 12 months randomization was disclosed and placebo group 
patients with persisting abdominal pain could request laparoscopic adhesiolysis. After 12 
year follow-up pain, QOL, medical history and analgesic intake were analyzed to assess the 
long term effects of laparoscopic adhesiolysis.
The study was approved by the ethics committee of each participating hospital. The study 
is registered with clinicaltrials.gov; the NCT ID is NCT02839564 .
Outcome measures
Primary outcome: long term pain relief.
Chapter 2
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Secondary outcomes: QOL, long-term complications, analgesic intake, rate of consulting 
medical doctors and additional surgery because of persisting abdominal pain.
Patients
Inclusion criteria:
Patients aged 18 years and above with chronic abdominal pain that was likely to be caused 
by adhesions due to previous abdominal surgery were recruited. Before attributing abdomi-
nal pain to the existence of adhesions all patients had an extensional diagnostic work-up to 
exclude other pathology.
Exclusion criteria:
1. Current treatment by psychologist or psychiatrist
2. Use of laxatives, sedatives, morphine, antipsychotics, antidepressants, or drugs that 
stimulate the central nervous system
3. Abnormal outcome of standardized non-invasive diagnostics: 
	 •	 Biochemical	investigation
	 •	 Lactose	tolerance	tests	or	H2	respiration	test
	 •	 Feces	analysis	of	worms	and	worm	eggs
	 •	 Ultrasound	or	CT	scan	of	the	abdomen
	 •	 Radiographic	studies	of	small	and	large	bowel	(or	colonoscopy)
Statistics
Analysis was by intention-to-treat (ITT) according to the Consolidated Standards of Report-
ing Trials (CONSORT) guidelines. 4 Preceding observations and a least squares regression 
were used in case of missing data. Proportions were compared with the Chi-square test and 
Fisher’s exact test. The Mann-Whitney U-test was used to analyze outcomes of the VRCS, 
VAS and SF36 . Changes compared to baseline were analyzed with the Student’s t-test and 
Wilcoxon’s signed rank test. The applied significance level was 5%. Statistical Analysis was 
performed using SPSS Statistical software (version 22.0, SPSS inc., Chicago, USA)
RESUlTS
A total of 80 patients (80%) were traced back for the 12-year follow-up (Figure 1). Five of them 
had died due to causes unrelated to abdominal pathology and 2 patients were demential 
and therefore excluded. Of the remaining 73 patients, 42 were allocated to laparoscopic 
adhesiolysis and 31 to placebo (laparoscopy alone). Of the 31 patients in the placebo group, 
12 underwent subsequent laparoscopic adhesiolysis after patients had their treatment 
arms revealed to them at one year. Baseline characteristics are shown in Table 1. By chance, 
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patients randomized to adhesiolysis had longer pre-study duration of pain than did patients 
randomized to the placebo group (30 vs 18 months).
Regarding the primary outcome 8 (19%) patients in the adhesiolysis group reported 
complete relief of abdominal pain against 13 (42%) patients in the placebo group (P=0.033, 
RR=1.3) (Figure 2). In both groups VAS scores improved signifi cantly (P>0.05, Table 2) during 
the fi rst 6 months of follow up and this was maintained throughout the remaining follow-up.
In accordance with the improved VAS scores both groups continued to register improved 
QOL scores especially for the items physical functioning, daily activities, social functioning, 
pain and vitality. Thereafter there was a signifi cantly further improvement compared to 
twelve months of follow-up for daily activities and physical functioning in the adhesiolysis 
group and pain and vitality in the placebo group.
Figure 1. Trial Profi le
Flow diagram according to the Consolidated Standards of Reporting Trials (CONSORT) guidelines; 
ITT = intention to treat; FU = follow up
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Table 2. Results of VAS and MOS SF-36 scores for the adhesiolysis and control group after 3, 6, 12 months and 
12 years.
Adhesiolysis group Placebo group P-value
No. of 
patients
Score 
(mean SEM)
No. of 
patients
Score 
(mean SEM)
VAS
0 months 52 57.2 48 56.0
6 months 52 38.6 ± 3.5 48 40.2 ± 4.2 0.77
12 months 52 38.9 ± 3.4 48 40.5 ± 3.7 0.63
12 year 42 34.1 ± 4.2 31 28.6  ± 5.1 0.29
MOS SF-36 score (pain part)
0 months 52 35.1 48 33.8
6 months 51 51.2 ± 3.0 47 50.1 ± 3.5 0.73
12 months 51 51.0 ± 3.3 47 49.7 ± 3.2 0.84
12 year 42 60.7 ± 29.1 31 62.3 ± 29.2 0.81
Data are given as mean ± standard error of mean (sem); VAS = visual analogue scale; MOS SF-36 = medical 
outcomes study with 36 item short-form health survey
Table 1. Patients and baseline characteristics
Characteristics Adhesiolysis group
n = 42
Placebo group
n=31
General features:
Age in years 45.1 (13.5) 48.8 (12.1)
Female/male 38/4 28/3
Body mass index 24.2 (18-37) 24.2 (19-30)
Pain factors:
VAS score 57.4 (18.2) 55.8 (17.3)
MOS SF-36 score 35.3 (16.2) 33.5 (15.2)
Duration of abdominal pain in months 30 (7-235) 19 (6-179)
Adhesion assessment:
Adhesions between organs:
Incidence 2 (0-7) 2 (0-6) 
Severity 2 (0-24) 3 (0-24) 
Adhesions between organs and the abdominal wall:
Incidence 1 (0-4) 1 (0-5) 
Severity 3 (0-16) 4 (0-16) 
Number of previous abdominal operations: 2.8 (1.5) 2.7 (1.5)
Type of previous operation: (no. of patients):
Open appendectomy 24 20 
Gynecological procedures 38 36 
Open bowel resections 6 14 
Data are given as mean (standard deviation) or median (range)
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Pain killers to relief abdominal pain were taken by 26 (62%) patients in the adhesiolysis 
group versus 16 (52%) patients in the placebo group (P=0.379, RR 1.72, 95% CI 0.8-1.8) (Table 
4). Persisting abdominal pain was reason to seek other consultants for 14 (33%) adhesiolysis 
patients and six (19%) placebo patients of which five had crossed over to adhesiolysis 
(P=0.186, RR1.33). Consulted were general surgeons, internists, gynecologists and neurolo-
gists (P=0.186, RR1.33). Patients were diagnosed with Irritable Bowel Syndrome, gastritis, ab-
dominal cutaneous nerve entrapment syndrome (ACNES), cholecystolithiasis, small bowel 
obstruction, ovarian cystic disease and mild diverticulitis. Another two were diagnosed with 
pancreatitis, which was regarded as a new disease because of normal serum amylases at 
preoperative work-up before trial participation).
Eight (19%) patients in the adhesiolysis group compared to one patient in the pla-
cebo group underwent additional surgery because of persisting abdominal pain (P=0.042, 
RR=1.67, 95% CI 1,208-2,318). The patient in the placebo group was actually a crossover 
patient and had a second adhesiolysis performed during long term follow-up. Of the pa-
tients in the adhesiolysis group three underwent a second adhesiolysis, two were operated 
because of ACNES, two because of ovarial cysts and one underwent an uterus extirpation.
Three long term complications were reported all appearing in the adhesiolysis group. 
There was one non strangulated cicatricial hernia and two admissions because of a small 
bowel obstruction. One was treated conservatively and one needed adhesiolysis.
Figure 2. Verbal rating pain change scores after twelve months and twelve year
Change of pain (VRCS score) for patients in the adhesiolysis and control group at 12 months and 12 year of fol-
low up compared with baseline (percentage of patients).
Significantly fewer patients in the adhesiolysis group reported being pain free compared to the non-adhesioly-
sis group (P=0.033, RR=1.3, Chi-square test).
ADH = adhesiolysis
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DISCUSSION
A randomized double blind placebo controlled trial was performed regarding the use of 
laparoscopic adhesiolysis for treating chronic abdominal pain. Compared were laparoscopic 
adhesiolysis to laparoscopy alone (placebo group). The one year results showed no benefit 
for the adhesiolysis group over the placebo (laparoscopy alone) group. After the 12 year the 
same findings were evident and even slightly worse for the adhesiolysis group.
Comparing our results to literature is challenging because of heterogeneity in study 
methods and consequently the reported outcomes with success rates laparoscopic adhe-
siolysis ranging between
16.7-97%. Since the surgical techniques differ only slightly between the studies, the 
discrepancy in success rates seems mostly due to methodological inconsistencies like 
the use of non-validated pain measurement tools, lack of a baseline measurement, low 
numbers of follow-up and inclusion of patients who had complaints not attributable to 
Table 3. Medical history of patients in the adhesiolysis and placebo group regarding chronic abdominal pain 
for the period between the short term analysis at 12 months and long term follow-up after 12 year.
Adhesiolysis group
No. (%)
Placebo group
No. (%)
P-value
RR CI 95%
Use of painkillers
Yes 26 (62) 16 (52) P = 0,379 
No  16 (38) 15 (48) RR 1,72 
   CI95% 0,79-1,812 
Medical analysis     
Yes 14 (33) 6 (19) P=0.186 
  among which are 5  RR 1,33  
  crossover patients CI95%  0,903-1,944 
No 28 (67) 25 (81) 
Re-operations
Yes 8 (19) 1 (3)  P=0,042 
  = crossover patient RR: 1.67  
No 34 (81) 30 (97) CI95% 1,208-2,318 
Type of re-operation:
Adhesiolysis 3 1
Uterus extirpation 1 -
Ovarian cystectomy 2 -
Neurectomy 2 -
Incisional hernia 1 -
Euthanasia because of pain 1 -
Analysis were with Fisher’s exact test
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adhesions.  5-18. One other randomized controlled trial addressing this subject was found. 
This well performed short term study by Peters et al reported no benefit of laparoscopic 
adhesiolysis over adhesiolysis alone which is line with our short and long term results. 3,5 The 
long term results are probably even underestimated, since the placebo patients that did not 
crossover to adhesiolysis did much better overall. Because of the intention to treat analysis 
these crossover patients are kept in the placebo group thereby underestimating the value 
of just the diagnostic laparoscopy.
In addition to the conclusion that laparoscopic adhesiolysis is inferior to just diagnostic 
laparoscopy / placebo, not overlooking the additional drawback of a higher peroperative 
morbidity (3% vs 0.1%), a second conclusion emerged from the study. 3 The laparoscopy 
alone showed to have a persisting and enlarging placebo effect during long term follow up, 
which as far as we know has not been previously reported. Clinical trials of surgical therapies 
are known for their placebo effects, but long term results are lacking.19 This may be due 
to the fact that surgical trials incorporating a placebo arm are rare and of short duration, 
because of debates on the ethics and feasibility of placebo in surgery. 20
The question arises how the longevity of the placebo effect can be explained. A placebo 
response is a psychobiological phenomenon in which expectations of benefit have an im-
portant role.21 if the perceived pain reduction with placebo matches the expectations of the 
patient it induces a sense of assurance.22 This causes a positive feedback loop maintaining 
pain reduction in placebo arms over long periods.23 The mechanisms responsible for the 
initial pain reduction in the both arms of this study might be the assurance that no seri-
ous pathology was found during the laparoscopy. The subsequent positive feedback loop 
turned out to be weaker in the adhesiolysis group which may be explained by the fact that 
laparoscopic adhesiolysis still inflicts new trauma to the sensitive peritoneum. This trauma 
results in neo-formation and reestablishment of adhesions with as long-term result, recur-
rent abdominal pain24. This decreasing success rate of adhesiolysis over time was described 
by Vrijland as well. 2
The conclusion that there is no advantage of adhesiolysis above placebo is weakened by 
the fact that by chance, patients randomized to adhesiolysis had longer pre-study duration 
of pain compared to the patients randomized to the placebo group (30 vs 18 months). In 
the first analysis no evidence was found that this is a factor that modifies treatment effect.3 
However it can be of influence on the long term results since preoperative pain is a risk 
factor for persistent post-surgical pain. For example because it may have caused persisting 
neurophysiologic changes and pain-related pathology like psychological vulnerability or 
stress. These factors are likely to be present in this patient population although patients 
under treatment of a psychologist or psychiatrist were not eligible for trial participation. 25 
This is however no assurance that psychological instability is not present illustrated by the 
fact that one crossover patient decided to have euthanasia because he was being sick of 
living with chronic abdominal pain.
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It is not clear why a considerable part of the placebo group applied to have adhesiolysis 
as yet, especially because of the same short term results compared to placebo. Probably the 
assurance after diagnostic laparoscopy that no serious morbidity was found did not provide 
enough relief to match the expectations of the patients needed for attenuating a positive 
feedback loop. Persisting pain may have caused them to hope that doing something is still 
better than to do nothing. Thereafter disease profit of ongoing medical attention may have 
been a driving factor.
A strong feature of this long term follow up study is the high number of patients after 
a long period of time (73% after twelve year) and few missing data. The reason patient 
participation at twelve year was more complete for the adhesiolysis group is not clear, but 
since the response rate is high for both groups, response bias is less likely.
CONClUSION
Laparoscopic adhesiolysis is not a beneficial treatment for patients with chronic abdominal 
pain attributed to adhesions and even results in worse outcome. Besides the risk of inad-
vertent enterotomy patients undergoing laparoscopic adhesiolysis have a smaller chance of 
becoming pain free, take more pain killers, have a higher consultation of medical doctors 
and are re-operated more often for persisting pain. Avoiding this treatment modality will 
result in less morbidity and health care costs. This study shows the powerful way in which 
placebo controlled trials can show non-efficacy of surgical therapies and the placebo effect 
to be powerful and long lasting. Without well-designed placebo controlled trials of surgery, 
ineffective surgical treatment may continue unchallenged.
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AbSTRACT
Purpose
Aim was to evaluate the long term effects of a self-adhering mesh not needing traumatic 
fixation devices on the incidence of chronic postoperative inguinal pain (CPIP) and recur-
rence rate after inguinal hernioplasty according to Lichtenstein.
Methods
Two groups of fifty consecutive patients, operated in 2008 with the self-gripping mesh 
(Progrip mesh, Covidien / Medtronic) or with a suture fixating polypropylene mesh, were se-
lected from a population of adult males with primary unilateral inguinal hernia. All patients 
were sent a SF-36 questionnaire and VAS score in December 2010. Three years later they 
were interviewed about recurrence and CPIP.
Results
41 study patients and 42 control patients were available for both points of follow-up. After a 
median follow up 30 months incidence of CPIP was 14.6% in the self-gripping mesh group 
and 23.8% in the suturing mesh group. After a median follow-up of 67 months this was 
reduced to 4.8% respectively 9.8% (NS). At 30 months CPIP affected daily life in 1 patient 
in the self-gripping group (2.4%) and 3 patients in the suturing group (7.1%) (NS). After 
67 months this was reduced to 0% respectively 2.4% (NS). Severe pain (VAS>70) was only 
seen in the suturing mesh group. Two recurrences were detected in the self-gripping mesh 
group and one in the sutured mesh group (NS). Operating time was significant shorter for 
the self-gripping mesh (p=0.000).
Conclusion
The findings presented here reflect the longest experience to date with the self-gripping 
mesh for inguinal hernioplasty. Although the self-gripping mesh appears not to reduce CPIP, 
it is efficient with no more recurrences and significantly reduced operating time.
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INTRODUCTION
The open Lichtenstein and endoscopic inguinal hernia techniques are still recommended as 
the best evidence-based options for the repair of a symptomatic primary unilateral inguinal 
hernia, providing the surgeon is sufficiently experienced in the specific procedure 1. In recent 
years chronic postoperative inguinal pain after hernioplasty (CPIP) gained much attention. 
CPIP has been defined as pain lasting more than three months after surgery 2. The reported 
frequency of CPIP varies widely because of different definitions used. In 2000, Poobalan 
et al reviewed the literature of CPIP and found incidences ranging from 0% to 63%  3. A 
similar range was reported by Aasvang and Kehlet in an update 4. The overall incidence of 
moderate to severe CPIP is estimated to be around 10–12% 1. Since surgical repair of groin 
hernias is one of the most commonly performed operations in the Western world and CPIP 
is especially effecting young otherwise healthy males, CPIP must be considered a major 
health problem 5. The etiology of CPIP is multifactorial among which is the surgical repair 
technique 1. This includes aspects like type of mesh used, its structure and interaction with 
tissue, method of fixation of the prosthetic material and handling of the cutaneous nerves 6. 
The use of non-absorbable sutures for mesh fixation has been cited as an important etiologic 
factor because of tension at anchor sites, additional foreign body reaction and entrapment 
of muscle and nerve fibers 7. A solution for this problem might be a self-gripping mesh 
(Parietene ProGrip®; Covidien): a polypropylene mesh with a one-sided coating of polylactic 
acid fiber hooks anchoring the mesh on to the tissue rendering additional fixating devices 
unnecessary. A number of clinical studies including clinical trials have been published to 
date comparing this particular mesh to the classic PPL mesh 8. Preliminary results have 
shown shorter operative times and lower incidences of CPIP. However, there is a lack of data 
about recurrence and chronic pain results in extended follow-up. The present study aims to 
report the long term differences in prevalence of CPIP and recurrence between a sutured 
mesh and a self-gripping mesh. It is presumed that a self-gripping mesh induces less CPIP 
and sensory loss without enhancing recurrence rate.
METHODS
In the department of general surgery of the Groene Hart Hospital, Gouda, The Netherlands, 
two groups of fifty patients, operated in 2008 with the self-gripping mesh (R/Progrip, 
Covidien USA) or with a suture fixating polypropylene mesh (Prolene, Ethicon, USA), were 
consecutively selected from a population of adult male patients with primary unilateral 
inguinal hernia, operated by two surgeons, performing the self-gripping mesh-technique 
and by six other surgeons, performing the suture fixating mesh technique. Exclusion criteria 
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for both groups were incarcerated inguinal hernia, ASA>3, coexisting chronic groin pain 
and being incapacitate. The self-adhesive mesh was introduced in the department in 2007.
All operations were performed by a surgeon or by a trainee under supervision. Operations 
were performed under spinal or general anesthesia in day care setting. Tension-free hernio-
plasty was performed with a 6×11 cm Prolene mesh or 12x8 cm Parietene ProGrip Mesh. The 
hernioplasty was accomplished according to the open tension-free repair of Lichtenstein. 
The incision, dissection of the sac in relation to the type of hernia, dissection of the anterior 
inguinal floor and closure of the wound with absorbable sutures were similar in all patients. 
The ilioinguinal, genitofemoral (genital branch) and iliohypogastric nerves were identified 
and preserved if possible in each case. In case of damage to the nerve or interfering with 
mesh or sutures the nerve was excised. Indirect hernia sacs were inverted or in case of 
a large sac transfixed at the base and excised. Direct sacs were inverted with absorbable 
sutures. Finally a local anesthetic (50mg chirocaine soluted in 10ml NaCl) was administered 
into the wound in both groups of patients. Operating time was scored starting from skin 
incision to completion of skin closure.
After informed consent patients from both groups were sent a SF-36 questionnaire and 
VAS score in december 2010 to assess the degree of CPIP and interference with activities of 
daily living. Three years later, January 2014, a telephone call was made and patients were 
asked about recurrence of the hernia and the existence of CPIP or sensory loss in the oper-
ated groin area and whether the pain interfered with social activities and work. In the case 
of CPIP they were asked to grade their present groin pain on a visual analogue scale. Data 
about medical history, per- and postoperative complications and operation details were 
collected from the clinical database.
Progrip mesh
The Parietene Progrip Mesh [manufactured by Medtronic (Group Covidien)] is a monofila-
ment mesh composed of polypropylene and resorbable polylactid acid (PLA) micro hooks 
for tissue gripping. Mesh fixation by the micro hooks to the underlying groin tissue is 
achieved instantly after exerting light pressure on the mesh. After the company the PLA 
micro hooks will be completely resorbed after 15 months and only the low-weight (40 g/
m2) monofilament polypropylene (PP) will be left in situ. The mesh has an oval shape with 
a self-gripping flap to be placed around the spermatic cord at the internal ring. The flap can 
be opened and reclosed facilitating corrections during mesh placement. There is a right and 
left sided version for optimal fitting of the mesh to the anatomical area.
Technic of mesh placement
In the suturing group the mesh was positioned against the posterior wall of the inguinal 
canal and sutured to the aponeurotic tissue over the pubic bone with a non-absorbable 
monofilament suture overlapping the pubic bone by 1.0 to 1.5cm (avoiding the pubic 
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periosteum). With a running PDS 2.0 suture the lower edge of the mesh was fixed to the 
inguinal ligament. Then the mesh was incised to create two tails which were placed around 
the spermatic cord in order to create a prosthetic internal ring. Both tails were overlapping 
each other with a single non-absorbable monofilament suture. Interrupted sutures were 
used to fixate the upper edge of the mesh to the conjoint tendon.
The Progrip mesh was placed tension free over the posterior wall of the inguinal canal 
overlapping the pubic bone and inguinal ligament by 1cm. The self-gripping flap was closed 
loosely around the spermatic cord as described by Chastan [25]. Fixation was achieved by 
applying light pressure on the mesh. No fixating suture(s) were applied.
Outcomes
The primary outcome of the study was the prevalence of CPIP with pain defined as a VAS 
score >10 [14]. Chronic pain was regarded as mild (VAS 10–30), moderate (VAS 31–60) or 
severe (VAS 70–100) [14]. Secondary outcomes included wound complications, operating 
time and recurrence rate.
Statistics
The statistical analysis was carried out using Statistical Package for the Social Sciences (SPSS) 
for Windows, version 9´01 (SPSS, Chicago, Illinois, USA). All tests were two sided and P < 0.05 
was considered significant. Dichotomous categorical data were compared using Pearson’s 
Chi-squared test or Fisher’s exact test for smaller groups. Continuous data were expressed 
as median (range) and compared with the Mann-Whitney U test.
RESUlTS
Within the group of 100 patients 83 patients (n=41 self-gripping mesh; n=42 suturing mesh) 
were available for long term follow-up (mean 67 months). Demographic details of patients 
and hernia types are shown in Table 1. There was no significant difference in response rate 
and characteristics between the two groups.
The median duration of operation was 37 min for the self-gripping and 47 min for the su-
tured mesh (p<0.001, Mann-Whitney U test, Table II). No perioperative complications were 
observed. Three post-operative complications occurred, all in the suturing mesh group (not 
significant, NS)): one postoperative hematoma, one seroma and one infection (epididymi-
tis). At the end of the study (median FU 67 months) two recurrences were detected in the 
self-gripping group and one in the suturing group (NS).
At the first cross sectional analysis in December 2010 (median follow up 30 months, 
range 26-35, Table III) CPIP defined as VAS>10 mm was reported by 14.6% patients in the 
self-gripping mesh group and by 23.8% patients in the suturing mesh group (OR 0.55, CI 
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0.179-1.681). CPIP affected daily life in 2.4% of the self-gripping group and 7.1% of the sutur-
ing group (NS).
At the second cross-sectional analysis in January 2014 (median follow up 67 months, 
range 63-72, Table IV) CPIP was reported by 4.8% respectively 9.8% (OR 0.59, CI 0.145-2.008) 
and affecting daily life in 0% respectively 2.4% (NS).
In those patients who reported CPIP, pain intensity was mostly classified as mild pain 
(VAS 10-30, Table III and IV). Severe pain (VAS>70) was only seen in the sutured mesh group. 
Two patients in this group were referred to a pain team. Sensory loss was reported by 15 
(36.6%) patients in de self-gripping group and 25 (61%) patients in the suturing mesh group 
(P0.0367).
Table 1. Patient and hernia characteristics
Suturing Mesh
N=41
Self-gripping Mesh
N=42
Age** 66 (24-89) 68 (21-89)
Sex ratio (F:M) 0:41 0:42
Body mass index (kg/m2) ** 24.8 (18.2–31.0) 25·0 (20.2-30.4)
Type of work*
Sedentary 13 (31.7) 11 (26.2) 
Physical 11 (26.8) 12 (28.6) 
Unemployed/retired 17 (41.4) 19 (45.2) 
Side of hernia* 
Left 24 (58.5) 23  (54.8) 
Right 17 (41.5)  19 (45.2) 
Type of hernia*:
Direct 12 (29.3) 10 (23.8) 
Indirect 26 (63.4) 28 (66.7) 
Combined 3 (7.3) 4 (9.5) 
Operator*:
Resident 35 (85.4) 38 (90.5) 
Surgeon 6 (14.6) 4 (9.5) 
Anesthesia*:
General 13 (28.6) 12 (31.7) 
Spinal 28 (71.4) 30 (68.3) 
Follow up ** (months) 67 (63-72)  67 (64-72)
*values in parentheses are percentages; **Values are median (range)
47
Self-gripping mesh for Lichtenstein hernioplasty; 5 year results
3
Table 2. Results
Suturing Mesh
N=41
Self-gripping Mesh
N=42
P
Operating time** 47 (34-87) 37 (17-97) 0.000 ¥
Neurectomy * 3 (7.3) 6 (14.3) 0.483$
Complications*:
Recurrence 1 (2.4) 2 (4.2) 0,616 $ 
Hematoma 1 (2.4) 0 0.517 $ 
Seroma 1 (2.4) 0 0.517 $ 
Wound infection 1 (2.4) 0 0.517 $ 
Testicular atrophy 0 0 
Prevalence of CPIP (%)
median FU 30 months* 10 (23.8) 6 (14.6) 0.312§ 
median FU 67 months* 4 (9.8) 2 (4.8) 0.353§ 
Interference with daily activities (%)
median FU 30 months* 3 (7.1) 1 (2.4) 0.317§ 
median FU 67 months* 1 (2.4) 0 0.517 $ 
Sensory loss 25 (61) 15 (36.6) 0.037§
*values in parentheses are percentages; **Values are median (range); ¥ Mann–Whitney U test; $ Fisher’s Exact 
Test; § Pearson χ2 test.
Table 3. VAS scores of the first cross-sectional analysis, median follow-up 30 months, OR for CPIP 0.55 (CI 0.179-
1.681) 
Chronic pain
<10 10-30 31-70 >70 median VAS range
Self-gripping mesh 35 5 1 0 0 0-40
Suturing mesh 31 7 2 1 5 0-80
Table 4. VAS scores of the second cross-sectional analysis, median follow-up 67 months, OR for CPIP 0,54 (CI 
0.145-2.008)
Chronic pain
<10 10-30 31-70 >70 median VAS range
Self-gripping mesh 40 2 0 0 0 0-20
Suturing mesh 38 2 1 0 15 0-40
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DISCUSSION
Our data indicate that a self-gripping Progrip mesh not needing additional suturing is safe 
and effective also after long term follow-up of 67 months. Compared to a sutured mesh there 
were no significant differences in incidence of CPIP (2% resp. 4%) and recurrences (4.2% 
resp. 2.4%). Furthermore the self-gripping mesh is easy to perform reflected in significant 
reduced operating times. It was expected that this self-gripping mesh bypassing traumatic 
fixation devices would lead to a reduction in CPIP compared to meshes traumatically fixated 
with sutures or staples. This hypothesis was based on the assumption that atraumatic fixa-
tion of a mesh would reduce the risk of compression and entrapment of muscle and nerve 
fibers leading to less muscle ischemia and neuroma formation 9. Indeed removal of sutures 
can be an effective treatment in patients with pain 10. Further on despite Lichtenstein being 
a tension-free method, fixation devices will still cause tension at anchor sites 7. Finally no 
fixation devices mean less foreign material and possibly a reduction of the foreign body 
reaction. This foreign body reaction is known to cause inflammatory damage to surround-
ing tissues and nerves and may induce a surplus of scar tissue leading to stiffness of the 
abdominal wall and a foreign body sensation 11. When using the Parietene Progrip mesh 
the need for traumatic fixating devices is bypassed by small absorbable micro hooks on 
the surface of the mesh. Chastan was the first to report the initial promising clinical experi-
ence with this self-gripping mesh 12. Since his publication a number of prospective studies 
and randomized controlled trials have compared the self-gripping mesh with a sutured 
mesh in Lichtenstein hernioplasty. Somme studies suggested that the incidence of CPIP 
was significantly reduced by using this mesh 13 while other studies did not confirm that 
14. The absence of a significant reduction of CPIP when using a self-gripping mesh may 
have several explanations. First the onset of CPIP is multi-factorial and not only caused by 
surgical related factors, but is also influenced by patient related factors. Patient risk factors 
for the onset of CPIP include young age, obesity, preoperative pain and pre-existing pain 
syndrome 6. Surgical risk factors do not only include type of mesh fixation, but also the 
repair technique itself, inadvertent nerve injury, postoperative infection, hernia recurrence 
and type of prosthetic material 15. It was argued that the reduction in foreign material by the 
absence of fixation devices would reduce the sometimes harmful effects of the foreign body 
reaction. However there is still the mesh causing this immune response. Thereafter it may 
have been too simplistic to suppose that the main difference between the meshes was the 
absence or presence of permanent sutures. The composition of the self-gripping mesh is 
different in that it has polylactic acid micro hooks on its surface. The inflammatory response 
to these micro hooks may differ from the response to polypropylene and sutures, affecting 
the extent of scar tissue formation and the probability of chronic nerve irritation. Further on 
establishing the anterior space as well as addressing the hernia sac should cause the same 
measure of trauma to the tissue irrespective of mesh attachment strategy. The results of the 
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Progrip mesh are in line with studies comparing another way of atraumatic fixation with 
fibrin sealant and glue fixation. A recent meta-analysis showed that there was no significant 
reduction in CPIP using glue or fibrin sealant compared to sutures or staples 16. Apparently 
the surgical trauma to the groin itself plays a crucial role in the development of CPIP. When 
performing a pre-peritoneal inguinal hernioplasty there remains the risk of injuring the in-
guinal nerves by other ways than fixation devices, e.g. by transection (neurectomy), by blunt 
or sharp dissection, diathermic heat or entrapment of the inguinal nerves by the mesh itself.
Recurrence rate was the same for both groups after a long term of 67 months suggesting 
the micro hooks provide satisfactory mesh fixation or at least equivalent to sutures. This is 
in accordance with median-term follow-up studies 14. Some even report no recurrent cases 
after 24 months with the use of the Progrip mesh 12. The difference may be due to our 
extended follow-up of 67 months or due to the fact that most patients were operated by 
supervised residents instead of surgeons.
Duration of surgery with the self-gripping mesh was significantly shorter. This must be 
due to the lack of requirement for sutures to secure the Progrip mesh and is consisting with 
other studies. 17. This is an important benefit of the Progrip mesh. Currently, the self-gripping 
mesh costs 2.5 times more than the comparable mesh of only polypropylene, but these 
increased costs are compensated by the reduced utilization of the operating room.
There are important limitations to the underlying study. Causes of CPIP are multifactorial. 
The number of patients included in this study is insufficient to show all important differ-
ences. Other drawbacks of the current study is that it was cross-sectional, not randomized 
and the analysis of the questionnaire was not blinded.
In conclusion, the findings presented here reflect the longest experience to date with the 
self-gripping Progrip mesh for inguinal hernioplasty. The self-gripping mesh appears safe 
and efficient with no more recurrences and significantly reduced operating time.
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AbSTRACT
Objective
To evaluate the effect of a self-gripping mesh (Progrip) on the incidence of chronic postop-
erative inguinal pain (CPIP) and recurrence rate after Lichtenstein hernioplasty.
Background
Chronic pain is the most common complication of inguinal hernioplasty. One of the causes 
may be the use of sutures to secure the mesh.
Methods
Adult male patients undergoing Lichtenstein hernioplasty for a primary unilateral inguinal 
hernia were randomized to a self-gripping polyester mesh or a sutured polyester mesh. 
Follow-up took place after 2 weeks, 3, 12, and 24 months. Pain and quality of life were 
assessed using the Verbal Rating Scale, Visual Analog Scale, and Short Form 36. CPIP was 
defined as moderate pain lasting at least 3 months postoperatively.
Results
There were 165 patients in the Progrip mesh group and 166 patients in the sutured mesh 
group. The incidence of CPIP was 7.3% at 3 months declining to 4.6% at 24 months and did 
not differ between both groups. Pain and quality of life scores were significantly improved 
after 2 years. Hernia recurrence rate after 24 months was 2.4% for the Progrip mesh and 1.8% 
for the sutured mesh (P 0.213). The mean duration of surgery was significant shorter with 
the Progrip mesh (44 vs 53 minutes, P < 0.001).
Conclusion
The self-gripping Progrip mesh does not reduce CPIP rates. Outcomes of the Progrip mesh 
are comparable to the Lichtenstein technique with the additional advantage of a reduced 
operation time. NCT01830452.
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INTRODUCTION
Surgical repair of groin hernias is one of the most commonly performed operations in the 
Western world. 1 Use of a prosthetic mesh became popular since recurrence and chronic 
postoperative inguinal pain (CPIP) rates are significantly lower than in autologous repair. 1,2 
In 1984 Lichtenstein popularized routine use of a heavy weight polypropylene mesh fixed 
with non-absorbable sutures to create a tension-free hernioplasty, thereby further minimiz-
ing postoperative discomfort. 1-4 However the occurrence of CPIP remains and is challenging 
modern inguinal hernia surgery. 5 
The onset of CPIP is multifactorial with patient related factors and technical factors.6-8 
Among the technical factors are the repair technique, nerve handling, postoperative com-
plications and type of prosthetic material and its fixation. 5,9-12 Several meta-analysis have 
shown that lightweight macroporous meshes are associated with a reduced foreign body 
reaction (FBR) reducing CPIP and foreign body feeling, although the incidence of severe 
CPIP is not decreased. 12-14 Since the use of penetrating mesh fixation can cause entrapment 
of muscle and nerve fibers focus of interest has switched to atraumatic fixation. 15,16 Fibrin 
sealant and n-butyl-2 cyanoacrylate (NB2C) glues have been reported to yield beneficial 
results. 17-21 The same was true for the use of absorbable sutures. 22 Another atraumatic way 
of mesh fixation may be found in the self-adhering Parietex Progrip mesh [manufactured 
by Medtronic (Group Covidien)]. This mesh incorporates a one side coating of resorbable 
polylactic acid micro hooks providing atraumatic anchorage of the mesh in the underlying 
tissue bed. This self-gripping mesh is supposed to reduce CPIP in bypassing traumatic fixat-
ing devices and using low-weight / large pore monofilament polyester hereby reducing the 
FBR. A number of clinical trials have been published to date comparing this specific mesh 
to a sutured mesh during Lichtenstein repair. However, there is little data on recurrence and 
CPIP in extended follow-up. The present study aims to report the clinical outcomes of a 
randomized controlled double blinded trial with a follow-up of two years.
METHODS
The HIPPO trial was a two center double blind randomized controlled trial conducted at 
two teaching hospitals, the Groene Hart Hospital and St Franciscus Hospital, The Nether-
lands. The aim was to compare two types of fixation for the same type of mesh in ventral 
inguinal hernia repair according to Lichtenstein as described by Amid4; a lightweight (46 g/
m2) polyester mesh sutured with 3-0 polypropylene was compared to a lightweight (38 g/
m2 after polylactic acid resorption) polyester mesh with self-gripping micro hooks (Parietex 
Progrip mesh, Medtronic (Covidien)). Before the start of the trial, experience with the Progrip 
mesh was gained by performing more than 50 procedures per center with this self-gripping 
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mesh. In addition Dr Chastan, the inventor of the Progrip mesh, was invited to the clinic to 
teach the correct technique of mesh placement. 23
Outcomes
Pain was assessed using a 6-point verbal rating scale (VRS) for day average pain and a visual 
analogue scale (VAS) for pain during daily activities and in rest. The primary outcome was 
the between group difference in the incidence of CPIP which was defined as moderate 
or more severe pain (VRS 3-6) lasting at least three months post-operatively. Secondary 
outcomes were the quality of life (QOL) which was assessed with the MOS SF-36 (medical 
outcomes study with 36 item short-form health survey), recurrence rate, perioperative and 
postoperative complications (e.g. wound infection, -hematoma or -seroma needing inter-
vention such as antibiotic treatment or drainage, urinary retention after spinal anesthesia 
defined as bladder volume of >500cc needing catheterization), operating time, length of 
hospital stay, mesh sensation and time until retaining daily activities.
Inclusion and exclusion criteria
All male patients aged ≥ 18 years with an uncomplicated primary unilateral inguinal hernia 
were eligible. Exclusion criteria were American Society of Anesthesiologists (ASA) ≥ 4 or 
impairment to adequate follow up (e.g. mental retardation, foreign language speaker, 
psychiatric disorder). Eligible patients received oral and written information about the trial 
and had to sign inform consent before participation. Preoperative baseline measures were 
obtained by filling in the VRS, VAS, SF36 and Dutch Inguinal Hernia questionnaire (to be 
validated). Pre-operative patient characteristics recorded were age, body mass index, medi-
cal history and employment status (Table 1).
blinding and randomization 
Randomization was performed by the operating theatre nurse using an official online ran-
domization program. The outcome of randomization was known by the surgeon not earlier 
than time of mesh placement. The investigator assessing the patient on the outpatient 
department and the patients themselves were not informed about the type of mesh that 
was placed and operation reports were coded.
Follow-up
Follow-up was at 2 weeks, 3, 12 and 24 months post-operatively to review pain, QOL and 
complications. At each moment of follow-up patients had to fill out the same question-
naires as before the operation.
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Surgical procedure
Patients were operated under protocoled general or spinal anesthesia by surgeons and 
supervised residents. Antibiotic prophylaxis was given according to the recommendations 
of the EHS. The inguinal hernia were corrected according to Lichtenstein, as described 
by Amid et al. 3,4 In the sutured mesh group a lightweight polyester mesh (Parietex Mesh, 
Medtronic (Covidien)) was fixed with non-absorbable 3-0 polypropylene (Ethicon, Johnson 
& Johnson, USA). In the Progrip mesh group a Parietex Progrip mesh was placed according 
to the description provided by Chastan. 23 In general, no fixating suture(s) were necessary, 
though in line with Chastan’s recommendations it was allowed by study protocol to place 
one absorbable stitch at the pubic tubercle if concern existed for adequate overlap infero-
medially. This extra stitch was recorded in the operation report.
Table 1. Baseline demographic data
Sutured mesh Progrip mesh
No. of patients 170 169
Age, yr * 61.4 ± 16.2 63.1 ± 14.6
BMI (kg/m2)* 24.98 ± 3.72 24.90 ± 3.45
Symptomatic hernia 50 (29.4) 48 (28.4)
Pre-operative VAS at rest * 68 ± 12 56 ± 17
Comorbidity
Smoking 50 (28.3) 61 (35.2) 
Use of anticoagulants  21 (12.0) 25 (14.7) 
Diabetes Mellitus  8 (4.8)   9  (5.5) 
COPD  6 (3.6)   5  (3.0) 
ASA fitness grade
1  98 (59.0) 96 (58.5) 
2 63 (38.0) 63 (38.4) 
3 5 (3.0) 5     (3.4) 
Work situation
Full time, salaried  68 (41.0) 50 (30.5) 
Full time, entrepreneur 16 (16.9) 19 (11.6) 
Unemployed 82 (49.6) 95 (57.9) 
Daily lifting
0-5 kg 15 (9.0) 25 (15.2) 
5-10 kg 84 (50.6) 79 (48.2) 
10-15 kg 26 (15.7) 22 (13.8) 
>15 kg 41 (24.7) 38 (23.2) 
Values in parenthesis are percentages unless indicated otherwise; 
* Values are mean ±SD; ASA American Society of Anesthesiologists; COPD Chronic Obstructive Pulmonary Dis-
ease
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The inguinal nerves were handled conform the recommendations of the EHS and Wijs-
muller et al; as a rule the nerves were preserved, but in case of damage or interference with 
the mesh they were cut and nerve endings were buried. 10,24 It was recommended that, in 
the case of a large hernia sac, transection of the hernia sac was performed and the distal 
hernia sac was left undisturbed, in order to prevent ischemic orchitis. If necessary, a large 
direct hernia was sutured tension-free with continuous soluble sutures until a flat posterior 
wall was created with a normal internal ring.
Operation characteristics recorded were nerve identification and handling, the type of 
the hernia and the size of the hernia defect, extra stitches and the duration of the operation 
in minutes.
Post-operative pain control and recovery
After hernia repair the wound was locally infiltrated with analgesics. Post-operative analge-
sics included paracetamol 1 gram 4 times daily, diclofenac 50 gram 3 times daily and opioids 
when indicated. According to the EHS no limitations were placed on patients following 
inguinal hernia operation.
Sample size calculation
The primary endpoint was the incidence of CPIP. A difference of 10 in post-operative VAS 
score between the intervention and control group was considered to be the minimum rel-
evant clinical difference. According to the power analysis, 169 patients per treatment group 
were needed to achieve this with a power of 80% with an alpha of 5%. The calculation was 
made with a two-sided test for the VAS pain score at 3 months. Based on a pilot study the 
standard deviation was set at 20.
Statistics
Analysis was by intention-to-treat however patients that were lost to follow-up within 3 
months were excluded, because no primary endpoint data were available. The CONSORT 
2010 Statement guidelines were followed for reporting this clinical trial. 25 Missing data were 
imputed on the basis of available preceding observations and by use of least squares regres-
sion. Statistical comparisons were made using the Wilcoxon test for continuous data and 
the Pearson chi squared test for ordinal data. The Wilcoxon test was used to analyze the SF36 
scores and nominal operative parameters. P<0.05 was considered statistically significant.
Ethical approval
The study was approved by the Regional Ethics Review Boards and conducted in accord with 
the ethical standards of the Helsinki Declaration of 1975. The trial protocol has been posted 
in the http://www.clinicaltrials.gov protocol registration system (identifier NCT01830452). 
There are no sources of funding.
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RESUlTS
During study enrollment from 2011 to 2013 395 patients with a primary unilateral inguinal 
hernia were assessed for eligibility of which 339 patients were fi nally included. Patients were 
randomized to the Parietex Progrip Mesh (n=169) or traditional Lichtenstein hernia repair 
with a sutured mesh (n=170) (Fig. 1). Demographic characteristics were comparable 
Figure 1. CONSORT fl owchart depicting number of patients during the stages of the study and the reasons 
for loss to follow-up
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between both groups (Table 1). One patient randomized to the Progrip mesh did not 
receive the allocated mesh, because no appropriate Progrip mesh was available. The rate 
of follow-up was 97.6% after three months declining to 90% after 24 months. Among the 
patients lost to follow-up were four patients (1%) who died from causes unrelated to the 
inguinal hernia repair and more than 12 months after surgery. Another four patients in each 
group were lost to follow up before the primary outcome could be measured at 3 months 
post-operatively and they were therefore excluded from the analysis. At 24 months 166 
patients were analyzed in the sutured mesh group and 165 patients in the Progrip mesh 
group.
baseline pain scores
Pre-operative pain scores were comparable between the groups (P>0.05). In the Progrip 
mesh group 48 (28.4 %) patients had preoperative inguinal pain defined as VRS3-6. In the 
sutured mesh group this number was 50 (29.4 %). The mean VAS for preoperative pain at rest 
was 56 ± 17 and 68 ± 12 in the Progrip resp. sutured mesh group.
Operative data
There were no significant differences in the operation and hernia characteristics between 
both groups, especially not for the nerve identification and nerve resection rate. Most 
patients were operated by residents under supervision of a surgeon and under spinal anes-
thesia (Table 2). Twenty-eight repairs with the Progrip group were done with an extra single 
stitch near the pubic bone.
Primary outcome
There were no significant differences between the self-gripping and sutured mesh group 
with regard to the primary outcome (Figure 2). The incidence of CPIP at 3 months was 7.3% 
(n=12) patients in the Progrip mesh group and 6.6% (n=11) patients in the sutured mesh 
group (P = 0.57). The incidence of CPIP declined during follow-up. After 12 months the 
incidence was 5.2% respectively 4.7% for the Progrip mesh and sutured mesh (p = 0.65) 
declining to 4.6 % respectively 5% after 24 months (p = 0.78).
Secondary outcomes
The number of patients with inguinal pain after 24 months was significantly declined com-
pared to baseline (P>0.001). The mean VAS scores in rest and during daily activities showed 
the same decline from 3 months and on worth and were not statistically different between 
both groups at neither point of follow-up (Figure 3).
Along with the decline in prevalence of CPIP and mean VAS scores during follow-up there 
was a decline in number of patients reporting to have numbness or foreign body feeling 
in the groin region or limitations during work or daily activities because of CPIP (Table 3).
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Table 2. 
Sutured mesh 
n=166
Progrip mesh 
n=1645
P
Operation performed by
Surgeon 36 (21.8) 29 (17.7) 0.663 
Resident 27 (16.4) 32 (19.5) 
Junior resident + Surgeon 98 (59.4) 97 (59.1) 
Junior resident + Senior resident 5   (2.4) 6 (3.7) 
Hernia characteristics
Indirect 96 (57.8) 108 (65.9) 0.561 
Direct 39 (23.5) 32 (19.5) 
Combined 31 (18.7) 23 (14.0 
Type of anesthesia
Spinal 119 (71.7)  123 (75) 0.947 
General 47 (28.9) 41 (25) 
Inguinal nerves: 
Number Identified or resected Identified Resected Identified Resected I:  0.494 
Ilioinguinal nerve 84 (68.3) 28 (20.0) 86 (67.7) 35 (24.6) R: 0.445 
Iliohypogastric nerve  44 (26.5) 10 (7.1) 38 (23.2) 6 (4.2) 
Genital branch of genitofemoral nerve 13 (7.8) 1 (0.7) 19 (11.6) 3 (2.1) 
Posterior reinforcement
Narrowing of the internal orifice
23 (14)
23 (14)
20 (12.3)
23 (14.2)
0.964
Extra suture medial / near pubic bone - 28 (17.3)
Figure 2. Verbal Rating Scale score for day average pain at different stages of follow-up for the self -gripping 
mesh and sutured mesh
m = months; P = Progrip mesh group; S = sutured mesh group; w = weeks.
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After 24 months this decline was significant (P=0.000) compared to two weeks post-
operatively. There was no significant difference between the groups.
QOL The overall QOL scores (SF36) and the pain part of the SF36 were significantly im-
proved (P=0.000) at 1 and 2-year of follow-up compared to the pre-operative phase (Figure 
4). There was no significant difference between the two groups.
Operating time The mean duration of surgery was significant longer for the sutured mesh 
(53.4 ± 12.5 min) compared to the Progrip mesh (44.4 ± 7.2 min) (p=0.001) (Table 3). Use of 
the Progrip mesh reduced the mean operating time with 17%.
Hospital stay No difference was observed in the length of hospital stay between the 
groups. Almost 90% of patients were discharged from the hospital at the day of surgery. The 
other 10% (mean age >70) had one overnight stay mainly because of social reasons.
Complications Wound complications occurred in nine patients that received the Progrip 
mesh and 13 patients with a sutured mesh: six respectively eight patients had seroma 
formation, one patient in both groups had an hematoma needing drainage in the operat-
ing room and two respectively four wound infections needed treatment with antibiotics 
(Table 3). Urinary retention after spinal anesthesia was detected in 3 of 199 (2.5%) patients in 
the Progrip mesh group and 4 of 123 (3.3%) patients in the sutured mesh group.
Table 3. Secondary outcomes
Sutured mesh Progrip mesh P
Operation time (min.)* 44.4 ± 7.2 53.4 ± 12.5 <0.001 
Length of hospital stay (days)* 1.3 (0.61) 1.2 (0.72) 0.999
Time until retaining work activities (days) ** 21.1 (2-32) 22.7 (2-36) 0.947
Post-operative complications:
Seroma 8 (4.8) 6 (3.7)  0.147 
Hematoma needing surgical nettoyage 1 (0.6) 1 (0.6)  
Wound infection treated with antibiotic 4 (2.4) 2 (1.2) 
Recurrence rate at 24 months 3 (1.8) 4 (2.5) 0.285
Mesh sensation 
2 weeks 101 (61.6) 101 (61.6) 0.901 
3 months 94 (57.3) 94 (57.3) 0.434 
12 months 67 (40.9) 67 (40.9) 0.698 
24 months 37 (22.6) ☨ 37 (22.6) ☨ 0.411 
Numbness 
2 weeks 91 (54.8)  85 (51.8) 0.961 
3 months 78 (47.0) 71 (43.3) 0.589 
12 months 59 (35.5) 44 (26.8) 0.086 
24 months 28 (16.7) ☨ 24 (14.6) ☨ 0.479 
Values in parenthesis are percentages unless indicated otherwise; * Values are mean ± SD
** Values are median (range) ☨ The number is significantly declined (P=0.000) compared with 2 weeks post-
operatively
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Figure 3. Visual Analog Scale (VAS) scores during daily activities and in rest for the Progrip mesh and sutured 
mesh. VAS scores were measured on a 1 to 100 mm scale and measured before operation (baseline measure) 
and postoperatively after 2 weeks, 3, 12, and 24 months. Values are mean (95% confi dence interval).
Figure 4. Pain part of the SF-36 quality of life score 
SF- 36 = short form 36; diff erences with baseline are all signifi cant except for 2 weeks of follow-up (P < 0.001).
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Recurrence The rate of hernia recurrence after 24 months was 2.4% in the Progrip mesh 
group and 1.2% in the sutured mesh group (P=0.213). Two recurrences in the Progrip group 
occurred in the first three months of follow-up. Both patients were operated by the same 
surgeon. The presence of a medial stitch did not influence recurrence rates.
DISCUSSION
Chronic pain is the main challenge of modern inguinal hernia surgery. In this double blind 
randomized controlled trial it was hypothesized that a self-adhering (Progrip) polyester 
mesh not needing traumatic fixation devices will cause less CPIP compared to a sutured 
polyester mesh. This hypothesis was not confirmed. The incidence of CPIP and the distribu-
tion of pain severity and QOL scores were almost the same for both type of fixating tech-
niques. However the Progrip mesh showed to have a similar outcome profile compared to 
the Lichtenstein technique, especially the same rate of recurrence after a follow-up of two 
years. The main advantage of the Progrip mesh seems to lie in its efficiency since operation 
times were significantly reduced.
The results presented here are in line with the results of previous randomized controlled 
trials. Except for the results presented by Kapischke et al trials comparing a sutured with 
a self-adhering mesh did not find reduced pain scores in favor of the self-adhering mesh. 
26,27-33 Apart from this, the reported incidence rates of CPIP vary widely among the trials. This 
can be caused by the heterogeneity in outcome parameters with different definitions of 
CPIP, timing and duration of follow-up and way of presenting outcomes. In the HIPPO trial 
the overall incidence of CPIP was 7.3% at 3 months declining to 4.6% at 24 months. This 
decrease of CPIP over time is in accordance with the findings of Eker et al (LEVEL-trial) and 
others concluding that spontaneous resolution of CPIP is the natural course.34-36 However 
the incidence of CPIP was still high after 24 months. This may be caused by the definition 
of CPIP which included all patients with moderate or more severe pain regardless whether 
it was influencing daily activities. Also, most patients were operated by trainee surgeons. 
The suggestion of Kingsnorth that a greater CPIP reduction with self-adhering devices may 
become apparent with less experienced surgeons, was not confirmed here. 26
The self-adhering mesh did not result in lower pain rates which may be due to the 
multifactorial onset of CPIP. Besides patient related factors there are multiple surgery re-
lated factors. 37,38 Of all these factors only the type of fixation was changed, but factors like 
handling of the inguinal nerves, the surgical approach and experience of the surgeons were 
unchanged. Thereafter the introduction of mesh and fixation devices will elicit a foreign 
body reaction (FBR) which is material dependent. In the HIPPO trial it was thought to use 
the same type of mesh in both groups, with the only difference the absence or presence 
of permanent sutures. However this is only true after the absorption of the polylactic acid 
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micro-hooks. Until that time the inflammatory response to polylactic acid micro hooks may 
differ and being more harmful compared to the response to polyester alone. This FBR is 
under current investigation of our research group. A third reason for the absence of reduced 
pain rates with the Progrip mesh may be the extra absorbable suture nearby the pubic 
tubercular placed in 17.3% of patients in the Progrip mesh group. Whether efforts should be 
made to avoid this suture to minimize the risk for postoperative neuralgia was investigated 
by Kingsnorth et al and Kohler at al. 27,39 They found that, among self-gripping mesh patients, 
those with medial fixation had significantly higher pain scores direct post-operatively and 
at 1- and 3-month follow-up. 27,39 Though at 1 year post-operatively no differences could 
be observed in terms of CPIP. In addition the medial stitch did not seem to influence the 
recurrence rate which is in line with the results of this trial.
In the HIPPO trial there were seven recurrences in the overall series, four of which were in 
the Progrip mesh group which was not significant different from the sutured mesh group. 
This is in line with other long term follow-up studies.30,40.
The duration of operation was the only outcome parameter to be significantly different 
in favor of the Progrip mesh. The lack of requirement for sutures to secure the Progrip mesh 
reduced the operative time significantly with 17%. This result is consistent with most other 
studies. 26-30,41,42. To date no cost effectiveness study has been performed comparing the two 
mesh repair techniques. Currently, the self-gripping mesh is three times more expensive 
than the non-self-adhering polyester mesh. The similar short- and long-term results of the 2 
groups enable surgeons to evaluate if raising the number of hernia repairs performed on a 
specific operating list would compensate for the higher price of the Progrip mesh.
To our knowledge, the HIPPO trial is the first RCT investigating the Progrip mesh combin-
ing a large number of patients (n=330) with a long term follow-up of 24 months. Another 
strong feature of this trial compared to others is the use of the same type of mesh in both 
groups except for the additional micro hooks on the Progrip mesh. A potential limitation is 
that patients were operated by different surgeons and surgeons in training and that nerves 
were not routinely searched for although this reflects the common situation in teaching 
hospitals. The results found could certainly have been strengthened by clinical examination 
at 24 months and quantitative sensory testing.
CONClUSION
This large scale double blind randomized controlled trial with a follow up of 24 months 
shows that Lichtenstein repair with a self-gripping Progrip mesh does not reduce the in-
cidence of CPIP , but has comparable hernia recurrence rates and is significantly faster to 
perform.
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AbSTRACT
Background
Complications after inguinal hernioplasty poses a significant burden on the individual 
patient and society because of high numbers of repair. Recently the long term results of 
a self-gripping Progrip mesh for open inguinal hernia repair became available. The aim of 
this meta-analysis was to compare these long term results to the results of a Lichtenstein 
hernioplasty with a sutured mesh focusing on chronic pain, recurrence rate, foreign body 
sensation and operation duration.
Methods
A systematic review of the literature was undertaken to identify randomized controlled 
trials (RCTs) comparing open inguinal hernia repair with a self-gripping Progrip mesh and a 
conventional Lichtenstein hernioplasty.
Results
In the present meta-analysis the outcomes of 10 RCTs enrolling 2541 patients were pooled. 
The mean follow-up was 24 months (range 6 to 72 months). There was no significant differ-
ence in the incidence of chronic pain [odds ratio = 0.93, 95% confidence interval (CI) (0.74-
1.18)], recurrence [odds ratio = 1.34, 95% CI (0.82-2.19)], or foreign body sensation [odds 
ratio = 0.82, 95% CI (0.65-1.03)], between the self-gripping mesh and sutured mesh group 
for all moments of follow-up. The mean operating time was significantly shorter [odds ratio 
= -7.58, 95% CI (-9.58- -5.58)] in the self-gripping mesh group.
Conclusion
The self-gripping mesh has comparable results to a sutured mesh regarding the incidence 
of CPIP, recurrence and foreign body sensation. However long-term results are still based 
on relatively small patient numbers and outcomes measures are heterogenic. The main ad-
vantage of the self-gripping mesh is the consistently significantly reduced operation time.
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INTRODUCTION 
The open hernia repair according to Lichtenstein and the endoscopic inguinal hernia 
techniques are still recommended as the best evidence-based options for the repair of a 
symptomatic primary unilateral inguinal hernia, providing the surgeon is sufficiently experi-
enced in the specific procedure.1 Factors popularizing the Lichtenstein technique over the 
endoscopic techniques are its easiness to perform, lower rate of serious complications and 
the possibility to perform the operation under local anesthesia.2-4 Since the recurrence rate 
for both techniques has been reduced beneath the rate of chronic postoperative inguinal 
pain (CPIP), CPIP and its consequences for the quality of life (QOL) are the challenges of 
modern hernia surgery.5 This is also urged by the high incidence of CPIP which lies around 
10% and because of its social-economic effects.1,5,6 The pathophysiology of CPIP is regarded 
multifactorial due to patient-related and surgery-related risk factors.6-9 Among the surgical 
risk factors are the type of mesh and its fixation technique.5,10,11 Several meta-analysis have 
shown that lightweight meshes are associated with less CPIP and less foreign body feeling, 
because of a reduced inflammatory response and a less intense foreign body reaction (FBR), 
although the incidence of severe CPIP is not significantly lower.12-14 It is thought that fixation 
of meshes with traumatic devices like sutures or tacks can cause entrapment and injury 
of muscles and nerve fibers.15,16 Numerous studies therefore aimed to reduce the need for 
fixating materials in tension-free hernia repair. Results of meta-analysis examining glue fixa-
tion of mesh are heterogeneous 17-20 Another atraumatic way of mesh fixation may be found 
in the self-gripping Progrip mesh (Medtronic). This bi-component semi-resorbable macro-
porous knit made of monofilament polypropylene (Parietene Progrip) or polyester (Parietex 
Progrip) incorporates a one side coating of resorbable micro hooks providing atraumatic 
anchorage of the mesh in the underlying tissue bed. The self-gripping mesh is supposed to 
reduce CPIP because of atraumatic mesh fixation and the use of low-weight monofilament 
mesh, hereby reducing the material dependent inflammatory reaction. Several randomized 
controlled trials compared the Lichtenstein repair using this self-gripping mesh with the 
Lichtenstein repair using a conventionally sutured mesh, and by now also long-term results 
of these studies have become available. Since former meta-analysis are based on short term 
results a new meta-analysis was performed to investigate differences in the occurrence of 
CPIP and recurrence rate between a sutured mesh and a self-gripping mesh on the long-
term.21-24
METHODS
The systematic review and meta-analysis was conducted following the Preferred Reporting 
Items for Systematic Reviews and Meta-Analysis (PRISMA) statement.25 All trials published 
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up to January 2017 comparing a self-gripping mesh and a conventional sutured mesh for 
the Lichtenstein procedure were identified. The literature search was performed in the fol-
lowing databases: Embase, Medline Ovid, CINAHL EBSCOhost, Cochrane, Web of science, 
Scopus, and Google scholar. The search strategy was designed by a Biomedical Informa-
tion Specialist of the Medical Library (Erasmus University Medical Center, Rotterdam, the 
Netherlands). A syntax with search terms was prepared and both the syntax and the search 
strategy are available in Appendix 1.
All identified records were transferred into an EndNote database (EndNote X7.7.1, Thom-
son Reuters). Two identical duplicate versions of this database were individually evaluated 
by two independent reviewers (M.M. and R.K.). First, all records were screened on title and 
abstract for eligibility. After this step, both independent libraries were combined and 
compared via an EndNote comparing strategy.26 Then all full-text articles were assessed 
for eligibility. Any discrepancies were discussed between the two reviewers and the senior 
author (J.F.L.).
Studies were included in the meta-analysis if they met all of the following inclusion crite-
ria: randomized controlled trials enrolling adult patients with a unilateral or bilateral primary 
inguinal hernia, hernia repair according to Lichtenstein comparing either a self-gripping 
polypropylene or polyester mesh (respectively: Parietene Progrip and Parietex Progrip mesh, 
Medtronic) with a conventional mesh being sutured; CPIP had to be among the primary 
or secondary outcomes. Articles had to be written in Dutch, English, or German. Interim 
analysis were excluded if an article with longer follow-up was available.
The following outcomes were extracted from the included trial: CPIP, foreign body sensa-
tion (FBS) and recurrence of hernia. The methodologic quality of the included studies was 
assessed according to criteria specified by the Cochrane handbook for Systematic Reviews 
of Interventions Version 5.0.1 and the guidelines of Jadad et al..27,28 In addition, all trials were 
scored on the availability of a baseline pain score, a validated assessment tool for CPIP, a defi-
nition of the outcome parameter CPIP, data about extra sutures placed in the self-gripping 
mesh group and perioperative nerve handling. Both reviewers independently sampled the 
data of all articles into a standardized database. This database was set up in Review Manager 
(RevMan) Version 5.3,The Cochrane Collaboration, 2014). A random check was performed by 
the senior author (J.F.L.).
Data Analysis
A random effects model was used to calculate a pooled mean of the data, taking into account 
both the variance between studies and study populations and the variance within a study.29 
For continuous data the mean difference with a 95% confidence interval (CI) was calculated, 
for dichotomous data the effect measures odds ratio (OR) and risk ratio (RR) with 95% CI 
were calculated to evaluate the statistical difference between outcomes. Since RevMan 5.3 
excludes trials with zero events when calculating an OR or RR, also a risk difference (RD) 
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was calculated in which zero event trials were included. Outcomes were displayed in forest 
plots. Statistical heterogeneity was assessed by calculating the test statistic Cochran’s Q. The 
consistency of study effects was tested using I² statistic.30 I² values of 0-25% was assigned as 
low, 25-50% moderate and 75-100% as high. In addition, the overall effect was provided for 
each total or subtotal. Two-sided p ≤ 0.05 was considered statistically significant. Analysis 
were performed using RevMan 5.3.
Outcomes not presented as mean (SD), but mean (range, 95% CI, interquartile range or 
nothing at all) were not included in the combined analysis.
RESUlTS
In total, 464 articles were identified after the removal of duplicates. After screening of these 
records 42 articles were found eligible for full-text assessment. After assessment of the full 
text versions, nine articles were suitable for inclusion in this meta-analysis. Another article 
was identified though a monthly mail summarizing recently published articles.31 During the 
writing of the meta0analysis the long term results of two already included studies were 
published and included in the meta-analysis.32,33 A PRISMA flowchart of the literature search 
is shown in Figure 1.
The included ten randomized controlled trials enrolled 2541 patients (n=1216 self-
gripping mesh group, n=1245 sutured mesh group). The length of follow-up ranged from 6 
to 72 months. Study characteristics are shown in Table 1A+B.
Methodologic quality of included studies
The quality assessment of the study methods according to the Cochrane guidelines is given 
in Table 2 including a Jadad Score. Three of the ten included studies scored less than 4 points. 
The quality of two trials was poor (2 points) due the absence of an adequate randomization 
technique or no information about it, absence of blinding, no power calculations, and no 
baseline score.34,35 The quality of one trial was moderate (3 points) due to the absence of 
blinding and baseline scoring.36 The study reported by Fan et al. scored 5 points although it 
was not powered for the outcome CPIP and did not provide a definition nor an assessment 
method of CPIP.31
Four studies did not perform a baseline pain score while pre-operative pain is a well-
known risk factor for CPIP.31,36-38 Four studies only performed a quantitative assessment of 
CPIP and no qualitative assessment with some kind of QOL score.34-36,39
Some trials compared different types of meshes in the two study groups instead of 
only changing the way of mesh fixation (polypropylene and polyester, and heavy and low 
weight).31,33,35,40
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CPIP defi nition
Besides Esteban et al. and Fan et al., all authors provided a defi nition of the primary or 
secondary outcome parameter CPIP.31,38 Three studies referred to the defi nition provided 
by the International Association for the Study of Pain (IASP) which states that ‘chronic pain 
is any pain that persists beyond the normal tissue healing time usually taken to be 3 
months.35,39,41,42 Three other studies used a threshold of a minimal VAS score of ≥ 30/10043, 
40/10036, or 45/15044 after which discomfort was regarded to be pain. Three authors used a 
time frame of 632 or 1233,43 months.
Meshes
In the study group, patients were treated with either a polypropylene self-gripping mesh 
(Parietene Progrip mesh, 64%) or a polyester self-gripping mesh (Parietex Progrip mesh, 
36%). In the control group diff erent meshes were used (i.e. heavy weight polypropyl-
Figure 1. PRISMA Flow Diagram
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ene31,33,35,40, low weight polypropylene38, Parietene Light39,43,44, Parietex Light42 or Optilene 
LP32. Five studies assessed meshes of the same material, construction, and weight in both 
the study group and the control group except for the additional polylactic acid micro hooks 
on the study group mesh.38,39,42,43
Chronic pain
CPIP was assessed in all trials and nine of them reported the incidence of chronic pain ac-
cording to the defi nition used in their study protocol.31-33,35,36,38,39,42,43 Incidence rates were 
analyzed separately for the diff erent moments of follow-up (3, 6-12, 24, 36, 72 months). 
Heterogeneity between the trials was very unlikely (P=0.87, Q/df< 1, I2 0%). For all moments 
of follow-up, there was no signifi cant diff erence in the incidence of CPIP between the 
self-gripping mesh and sutured mesh group [3 months OR = 0.89, 95% confi dence interval 
(CI) (0.48–1.64), 6-12 months OR = 1.00, 95% CI (0.75–1.34), 24 months OR = 1.00, 95% CI 
(0.39-2.61)], 36-72 months OR = 0.77, 95% CI (0.38-1.58)]. The forest plot is shown in Figure 
2A. A subgroup analysis (Figure 2B) accounting for mesh weight and including only studies 
that used a light weighted mesh in both the study and control group also showed no dif-
ference in CPIP rates between the self-gripping mesh and sutured mesh OR = 0.89 95% CI 
(0.68-1.16)].32,34,42,45,46 
All studies except that of Fan et al. presented an assessment of the intensity of chronic 
pain, but diff erent assessment methods were used. Although all had a VAS score amongst it, 
both a 0-100 and a 0-150 mm scale were used. Also, outcomes were presented in diff erent 
ways hindering a combined analysis. However, none of the studies reported a signifi cant 
diff erence in pain intensity scores for CPIP between the two kinds of meshes.
A combined analysis of the quantitative assessment of CPIP – refl ecting the infl uence of 
CPIP on daily life – was not possible, since the four studies that used this kind of measure 
(SF12, SF36, AAS) did not provide full outcomes.42-44,47 The separate studies did not fi nd 
signifi cant diff erences in the QOL scores between the two meshes, except for Pierides et 
al. who found signifi cantly improved social functioning in favor of the self-gripping mesh.45
Foreign body sensation 
Five studies reported the rate of FBS. There was no heterogeneity amongst the trials (P=0.86, 
Q/df< 1 and I2 0%). No one reported a signifi cant in between group diff erence for the rate 
of FBS although the combined analysis showed a trend towards less FBS in the self-gripping 
mesh group. (Figure 3) A subgroup analysis (not shown) corrected for mesh weight also 
did not reach signifi cance. Incidences were declining during follow up except for the study 
population of Zwaans et al who reported an higher incidence after three years compared to 
one year postoperatively.33 
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Figure 2A. Incidence of CPIP
Figure 2B. Incidence of CPIP including only light weighted meshes
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5Recurrences
All trials reported recurrence rates after 12 months of follow-up, 2 studies also provided 
recurrence rates after 24 months35,42, 2 after 36 months 32,33 and 1 after 72 months31. There 
was no heterogeneity amongst the trials (P=0.41, Q/df< 1 and I2 4%). The diff erence in recur-
rence rate between the self-gripping mesh group and the sutured mesh group was not 
signifi cant neither at 12 months [OR = 1.19, 95% CI (0.61 to 2.31), nor at 24 months [OR = 
1.06, 95% CI (0.27 to 4.17)] nor at 36 months [OR = 0.95, 95% CI (0.18 to 5.14)]. A RD analysis 
showed the same results [12 months RD = 0.00, 95% CI (-0.01 to 0.01), 24 months RD = 0.00, 
95% CI (-0.03 to 0.03)] (Figure 4).
Extra stitch in the self-gripping mesh group
In seven of the ten studies in this meta-analysis no extra sutures were placed in the self-
gripping mesh group.31-33,38-40,43 The three studies that allowed an extra stitch according to 
the instructions of Chastan did not perform a subgroup analysis.35,42,48 49
Nerve handling and paresthesia
Except for Esteban et al. all trials tried to identify and preserve the inguinal nerves and four 
reported the actual rates of nerve identifi cation and resection. 33,42,44,46 The techniques of 
nerve division of a suspected injured nerve were not clear from the study methods and 
numbers were not always recorded (Table 1B). Five studies investigated post-operative 
numbness in the groin region.32,33,39,42,43 They found no signifi cant diff erence in numbness 
between the two mesh fi xation methods and also reported comparable rates of nerve 
resection for the two study groups. Sanders et al. performed a subgroup analysis on the 
impact of nerve resection and mesh fi xation method on CPIP and found that when the 
Figure 3. Foreign body sensation
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iliohypogastric nerve was preserved, postoperative pain was signifi cantly lower in the self-
gripping mesh group than the sutured mesh group at all follow-up points from discharge 
to 1 year postoperatively. There was no signifi cant diff erence between the groups when the 
iliohypogastric nerve was resected.48 Zwaans et al reported no relation between hypoesthe-
sia or hyperesthesia and previous neurectomy.33 
Operation duration 
Five studies reported mean operating time with SD and could contribute to the combined 
analysis (Figure 5). The mean operating time was signifi cantly shorter in the self-gripping 
mesh group than in the sutured mesh group [mean diff erence was -7.58, 95% CI (-9.58 - 
-5.58)]. There was a high heterogeneity direction of eff ect and the eff ect size was high and 
Figure 4. Recurrence rate
Figure 5. Operation Duration
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significant, Z = 7.44 (P < 0.00001). The trials which could not contribute to the combined 
calculation confirmed this significant reduction in operating time for the self-gripping mesh. 
The mean reduction in operation time ranged from 1.43 to 10 minutes (=17%).42
DISCUSSION 
Chronic pain and recurrence are the main complications of inguinal hernia surgery and 
needs to be studied during long-term follow-up. Recently four large trials published their 
long-term results comparing the self-gripping mesh with a sutured mesh for open inguinal 
hernia repair and therefore a new meta-analysis was performed, focusing on these long-
term results.31,33,42,48 In line with the individual studies the meta-analysis showed no signifi-
cant benefits regarding the incidence of CPIP, FBS and recurrence rate. The main advantage 
of the self-gripping mesh thus lies in its efficiency thereby significantly reducing operative 
times. Previous meta-analysis reported similar outcomes but the inclusion of studies with 
short term follow-up, low inclusion rates or no randomization limits their conclusions .21-23,50 
The negative results should be interpreted through surgical- and patient- related factors as 
well as methodological factors.
Before looking at the pathophysiological factors of CPIP there are methodological issues 
to address when a study fails to reach its primary outcome.51 First, is there an indication of 
benefit using a self-gripping mesh? It was hypothesized that a self-gripping lightweight 
mesh would lower the incidence of CPIP, because of avoiding traumatic suture fixation, and 
reducing the amount of foreign body reaction because of its material reduced structure. 
Although this hypothesis is reasonable because of expected reduction of neuropathic and 
nociceptive pain stimuli, it is however too simplistic. Only the fixation method and material 
weight of the mesh are changed, but not for example the surgical approach, which still 
needs dissection in a neuralgic plane. Therefore some will wonder why to perform an open 
anterior approach at all, since laparoscopic techniques have shown faster recovery times 
and lower chronic pain risk.52,53 This disregards the obligation that surgeons have to tailor 
treatments based on expertise, local/national resources, and patient related, and hernia 
related factors. For high-risk inguinal hernia patients with extensive co-morbidities or pa-
tients with pelvic scarring, an open mesh repair (under local anesthesia) is still the preferred 
technique as is the case for recurrent inguinal hernia after laparoscopic repair according to 
the world guidelines for groin hernia management 2016.
A second contributor in failing of the primary outcome may be studies to be underpow-
ered since half of the studies enrolled less than one hundred patients. This meta-analysis 
should address the limitations of study size of individual RCTs, however not all RCTs could 
contribute to the combined analysis, because of differences in outcome measures. The 
combined analysis for the between group difference in incidence of CPIP after 6-12 months 
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was based on the response of 750 patients in de self-gripping mesh group and 767 patients 
in the sutured mesh group. After 36 months, these numbers were 231 respectively 233 per 
group for the incidence of CPIP and recurrence rate. Hence the long-term conclusions about 
CPIP and recurrence rate are still based on relatively low patient numbers which lowers the 
strengths of the results.
Other questions to be asked are whether the trials had deficiencies in their treatment 
regimen, the population studied, and the trial conduct. The latter is a focus of concern for 
two studies since they had an inadequate randomization technique, no blinding, no power 
calculations, and no baseline score.34,35 In addition two other studies did not perform a base-
line pain score while pre-operative pain is a well-known risk factor for CPIP.31,36 Thereafter 
four studies lacked to perform a qualitative assessment of CPIP to evaluate the influence of 
CPIP on daily life and well-being.
Meta-analysis should be conducted when a group of studies is sufficiently homogeneous 
in terms of subjects involved, interventions, and outcomes to minimize performance and 
measuring bias so to provide a meaningful summary. This was reason to include only RCTs 
that compared the two meshes for a Lichtenstein hernia repair in adult patients with a 
primary hernia. Recurrent hernias were excluded because this is a risk factor for the develop-
ment of CPIP. Although the strict inclusion criteria there was still heterogeneity amongst 
the trials in this meta-analysis, caused by clinical and methodological variation. Firstly, the 
hernia repairs were performed by different surgeons and with different levels of experience 
(trainees, general surgeons, hernia specialists). It is known that there is a substantial dispar-
ity between the state-of-the-art Lichtenstein repair and its application in general practice, 
especially with respect to steps that are suggested to play a role in the origin of chronic 
groin pain.54 Other clinical variations that could modify the intervention effect were different 
types of anesthesia (spinal, general, regional), use of different meshes in the conventional 
Lichtenstein group (both heavy weight and light weight), differences in the way of nerve 
handling, timing of follow-up and whether an extra stitch was allowed for the self-gripping 
mesh. However, this clinical heterogeneity reflects daily practice and will therefore be of 
less influence on the generalizability of the results. Methodological variation was caused by 
the variable definitions and assessment methods for CPIP and the unstandardized way of 
presenting outcomes. This caused that only comparisons could be made for between group 
differences in CPIP rates, but not for incidence rates of CPIP overall or special subgroups. This 
methodological heterogeneity is a common problem in hernia research and is hindering 
comparison of outcomes to draw firm conclusion.55-57
Regarding surgical factors there are several discussions specific for the self-gripping mesh. 
First there is discussion on the influence of the extra stitch in the self-gripping mesh group; 
this stitch is placed near the neuralgic pubic tubercle to prevent a medial recurrence. The 
RCTs in this meta-analysis did not perform subgroup analysis whether the stitch induced 
more CPIP in patients. However a recent evaluation of the Herniamed register did not find 
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a correlation. The same applies to recurrence rates.58 From this it may be concluded, that 
although seemingly of no influence on CPIP rates, it could be recommended to avoid the 
single stitch in this neuralgic place especially in the case of small or medium size hernias. 
A second consideration is the influence of the additional polylactic acid micro hooks. It is 
possible that the presence of micro-hooks and their disintegration exaggerates the foreign 
body reaction leading to inflammatory damage to surrounding nerves. This was not seen 
in experimental models and human studies are not available.59 However since CPIP and 
FBS rates are not increased for the micro hook added meshes the inflammatory reaction to 
these micro hooks seems be of less influence. But since the foreign body reaction decreased 
over time there may be a relation with the resorption of the micro hooks which are com-
pletely resorted at 12 months postoperatively. Zwaans and colleagues were the only one 
to report increased FBS during follow-up especially for their heavy weight sutured mesh 
group. Thereafter a possible augmented inflammatory reaction may be counterbalanced by 
the light weight nature of the self-gripping mesh, since light weight meshes are known to 
induce less fibrosis and hence less FBS. This brings us to the third factor of discussion, the 
influence of the light weight microporous structure of the Progrip mesh. This was supposed 
to augment the pain reducing effect of the atraumatic fixation, but they together failed to 
do so.
Nerve injury, during dissection or mesh placement and fixation (or afterwards by the 
inflammatory reaction), is regarded to be one a the most important causative factors for 
CPIP and therefore nerve handling is important to report.60 Almost all studies reported try-
ing to identify and protect the nerves and to resect nerves that were accidentally damage 
or in the way of mesh placement, but only four studies reported identification and resec-
tion rates.33,42,44,46 These were comparable for the self-gripping and sutured mesh groups 
hence do not seem to influence the between group results. Sanders et al and Zwaans et al 
performed sub analysis after the effect of neurectomy and found no significant influence of 
neurectomy on the rates of CPIP or an altered sensation in the groin.33,44 
Finally, patient-related risk factors need to be addressed. Known risk factors for the 
development of CPIP are moderate to severe preoperative pain >1 month, psychological 
vulnerability, female gender, younger age and genetic predisposition. They are often under-
estimated compared to surgical factors, but there is increasing awareness of the individual 
variance in foreign body reaction and sensory disturbances that may or may not lead to 
CPIP. Hence these patient related risk factors need to be considered in the indication for 
surgery, which in the futures can be facilitated with tests like genotyping and quantitative 
sensory testing.9,60-62 
In this meta-analysis we did not address acute post-operative pain, because we wanted 
to report the long term results of self-gripping mesh. However acute post-operative pain 
is one of the strongest and most consistent risk factors for CPP urging an approach of so-
called “preventive or preemptive analgesia” by the use of pre-operative local anesthesia.63-65.
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Several conclusions can be made. First, a self-gripping mesh has comparable results to a 
sutured mesh regarding the incidence of CPIP and recurrence. Secondly, the self-gripping 
mesh does not solve CPIP however conclusions on long-term results are still based on 
relatively small patient numbers. Third, there is high heterogeneity in CPIP definition, assess-
ment, and presentation of outcomes, making it hard to compare incidence rates. There must 
be a call for a more uniform methodology. Last, the main advantage of the self-gripping 
mesh is its efficiency with consistently significantly reduced operation times. To date no 
cost-effectiveness study has been performed, but when the reduction time up to 17% is 
translated into better utilization of operating theatre resources and manpower, the higher 
price of the mesh could be amply compensated.
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AbSTRACT
Background
Chronic pain is the main complication in inguinal hernia surgery. Among the etiologic 
factors are mesh fixation and biocompatibility. To bypass mesh fixation, supplementary 
polylactic acid micro-hooks were added to a lightweight monofilament polyester mesh to 
provide for self-gripping properties in inguinal hernia repair. This study was designed to 
evaluate the influence of this additional polylactic acid on the biocompatibility of polyester 
mesh by determining the direction of the foreign body response (FBR). The direction of FBR 
is mainly determined by macrophages.
Methods
The self-gripping polyester mesh (Parietex Progrip) was compared to a pure polyester mesh 
(Parietex). To investigate the reaction of macrophages to these meshes, macrophages were 
cultured in our human macrophage in vitro model and pro- and anti-inflammatory cyto-
kines were measured in the culture medium.
Results
There was no significant difference between the two meshes in the production of pro 
inflammatory cytokines by M1 macrophages and anti-inflammatory cytokines by M2 mac-
rophages. The two meshes had almost the same M1/M2 index.
Conclusion
It was concluded that polylactic acid micro-hooks does not seem to have a significant influ-
ence on the FBR of macrophages. Biocompatibility of a composited polyester polylactic acid 
self-gripping mesh seems to be comparable to a standard polyester mesh.
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INTRODUCTION
Meshes for abdominal wall hernia repair are probably the most common used biomaterials 
implanted in surgery. The use of a prosthetic mesh is the gold standard in hernia repair, 
since recurrence rates are significantly lower compared to autologous repair 1. The down-
side of mesh implantation includes mainly chronic pain, foreign body feeling, and infection. 
Chronic postoperative inguinal pain (CPIP) is a prominent issue in inguinal hernia repair 
research as its persisting appearance is a severe complication, occurring in 11% of patients 2.
The onset of CPIP is multifactorial with patient and surgery related factors.3,4 Of the surgi-
cal factors nerve damage plays a pivotal pathophysiological role and may be caused by 
transection (neurectomy), blunt or sharp dissection, diathermic heat or entrapment of the 
inguinal nerves by the mesh or sutures 2. Furthermore the implanted prosthetic material 
(mesh and sutures) in the inguinal canal elicits an inflammatory and fibrotic response that 
imparts strength to the hernia repair, but on the other side causes neuropathological effects 
in adjacent nerves by thickening of collagen layers around axons and generalized axonal 
degradation and loss 5,6. This inflammation or foreign body reaction (FBR) is highly material 
dependent. Weight reduced large pore size meshes seem to result in a diminished FBR and 
consequently less chronic pain and foreign body sensation during the first post-operative 
year 7. Regarding fixation, meta-analysis on the use of atraumatic fixation of the mesh with 
glue are inconclusive. One reports no benefit on the use of glue 8 in contrast to others we 
report a reduction of CPIP 9,10 whereas De Goede et all only found glue to reduce acute pain 
but not CPIP.11 Subsequent meta-analysis The same is seen for the use of atraumatic devices 
or materials like glue to secure the mesh to the anterior wall 11-13.
A combination of atraumatic fixation and light weight material is found in the self-gripping 
Parietex Progrip mesh. This bi-component knit of polyester (PET) incorporates resorbable 
polylactic acid (PLA) micro hooks on one side of the mesh, which provides atraumatic an-
chorage of the mesh in the underlying tissue instantly after application. Tissue-gripping is 
achieved during the following twelve months and does not require additional fixation. After 
resorption of the PLA-part of the mesh, only the low-weight PET fabric (40 g/m2) remains 
in the groin area, providing the long-term wall reinforcement. Besides to ease initial surgi-
cal handling, this self-gripping mesh is supposed to reduce CPIP in bypassing traumatic 
fixating devices and eliciting a reduced inflammation and FBR, because of the low-weight 
large pore size monofilament knit. However, a number of randomized controlled trials and 
meta-analysis did no report reduced CPIP rates 14-20. An explanation may be found in the PLA 
micro-hooks to elicit a different, more harming inflammatory reaction thereby reducing the 
mesh biocompatibility.
Biocompatibility of a mesh can be expressed as the ability of the device to perform its 
intended function, with the desired degree of incorporation in the host, without excessive 
fibrosis and inflammatory damage to nerves and tissue 21. Macrophages have an important 
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role in directing the intensity and balance of the host immune response. Macrophages can 
have different phenotypes, with pro-inflammatory (M1) and anti-inflammatory/wound heal-
ing (M2) on both ends of the spectrum. These two types are influenced by different factors 
and produce different cytokines (Table 1). From the release of cytokines by macrophages, 
an artificial M1/M2 index can be calculated indicative for a more pro- or anti-inflammatory 
reaction of macrophages to meshes. This is greatly influenced by the biophysical nature of 
the material with which the macrophages interact 22,23.
This study was designed to evaluate the influence of additional PLA on the mesh and 
how it influences the acute response of macrophages by assessing the cytokine profile of 
macrophages seeded on the mesh by the use of our earlier published in vitro model of hu-
man primary macrophages 24. We determined the production of pro- and anti-inflammatory 
cytokines to investigate the reaction of macrophages to the PLA addition to a polyester 
(Parietex) mesh.
METHODS
A full description of monocyte isolation, validation of read out parameters and macrophage 
culturing has been published previously by our team [24]. A summarize will be given for 
proper understanding of the results presented.
Table 1. Main characteristics of M1 and M2 macrophages
M1 M2
Function pro-inflammatory
anti-fibrogenic
tissue destructive
anti-inflammatory
pro-fibrogenic
promote FBGC formation
Genes TNFα
IL 6
 CD 206
CCL 18
Stimulators
used in the study protocol
LPS
IFN-γ 
IL-4 
Cytokines (proteins)
most discriminative ones
MIP-1α or CCL3
TNFα
MCP-3 
IL-1β 
IL-6
CCL5
CCL18
IL-1RA
MDC
FBGC=Foreign Body Giant Cell, IL=interleukin, MIP=macrophage inflammatory protein, TNF=tumor necrosis 
factor, LPS=lipopolysaccharide, IFN=interferon, MCP=monocyte chemotactic protein, RA=receptor antagonist, 
RANTES=regulated upon activation normal T-cell expressed and secreted, MDC=macrophage derived chemo-
kine, CCL=chemokine ligand
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Monocyte isolation
Ficoll density gradient (Ficoll-Paque™ PLUS, GE Healthcare) was used to isolate monocytes 
from 3 buffy coats of healthy donors, obtained from the blood bank (SanquinBloodbank, 
Rotterdam, the Netherlands). [24]
Meshes
Macrophage reaction was tested for a bicomponent semi-resorbable knit of non-absorbable 
monofilament polyester and resorbable monofilament polylactic acid (PLA). The results 
were compared to a low weight polyester mesh (Parietex. Both meshes were from Sofradim 
Production, A Medtronic Company, Trevoux, France (Table 2).
Culturing macrophages on biomaterials
The meshes were cut into pieces of 1.5 by 1.5 cm. After seeding samples were placed in a 
24-well non-adherent plate (NUNC, non-treated multiplate, Rochester, NY, USA) and cul-
tured for a total of 3 days in serum free X-vivo 15 medium. The samples were harvested after 
3 days for protein production and DNA analysis.
Cytokine analysis
We previously determined a panel of proteins and genes to define several distinguishing 
markers for pro- and anti-inflammatory macrophages using lipopolysaccharide (LPS) + 
interferon (IFN)-γ and interleukin (IL)-4 stimulated macrophages. Protein production was 
measured for nine proteins; macrophage inflammatory protein (MIP)-1α (or chemokine 
ligand (CCL) 3), tumor necrosis factor (TNF)α, interleukin (IL)-1β and interleukin (IL)-6 as 
pro-inflammatory M1 markers, macrophage derived chemokine (MDC or CCL22), mono-
cyte chemotactic protein (MCP)-3, regulated upon activation normal T-cell expressed 
and secreted (RANTES or CCL5), interleukin (IL)-1RA and chemokine ligand (CCL) 18 as 
anti-inflammatory M2 markers. Although IL-6 and RANTES are known to be able to act 
either pro-inflammatory or anti-inflammatory, depending on the environment [24], in our 
monolayer experiments with stimulated macrophagesIL-6 gene expression was higher in 
LPS+IFNc stimulated macrophages than in IL-4 stimulated macrophages. Therefore IL-6 was 
Table 2. Mesh materials used
Trade name Chemical 
component
Type Filament / 
constitution
Pore size 
(mm)
Mass 
(g/m2)
Parietex LW PET Non-absorbable Monofilament 1.5x1.5 46
Parietex 
Progrip
PET + PLA Non-absorbable PET 
and absorbable PLA
Bicomponent, both 
monofilaments
Macro: 
1.8 x 1.8
82
after adsorption of PLA: 49
LW = low weight; PLA = polylactic acid; PET = polyester
All were from Sofradim Production, A Medtronic Company, France
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selected as pro-infl ammatory marker. RANTES protein levels on the other hand were higher 
in IL-4 stimulated cells than in LPS+IFNc stimulated cells and therefore selected in our model 
as an anti-infl ammatory marker. [24] Cytokine measurement was done using an eight-plex 
Milliplex (Millipore) and a CCL18 DuoSet ELISA (R&D, Minneapolis, MN, USA).
DNA measuring
The amount of protein was corrected for the number of cells by measuring DNA. The seeded 
meshes after 3 days of culture were harvested in 0.1%Triton/PBS (Sigma–Aldrich) and stored 
at -20°C. Later the samples were analyzed with CyQUANT© cell proliferation assay kit (Invit-
rogen, Carlsbad, CA, USA) according to the manufacturer’s recommendation.
Statistics
The biomaterial experiments were performed with three diff erent donors, each donor in 
triplicate. All data are presented as scatter dot plots with each dot representing one single 
measurement with the mean of the diff erent donors. To compare the eff ect of the four 
materials on macrophage subtype, a relative M1/M2 index was calculated. The percent-
age of the mean production per cytokine was calculated, followed by dividing the mean 
percentage of M1 cytokines (MIP-1a, TNFa, MCP-3, IL-1b, IL-6) by the mean percentage of 
M2 cytokines (MDC, RANTES, IL-1RA and CCL18) per sample. Groups were compared in SPSS 
(20.0, IBM Corporation, Armonk, New York, USA) using a Kruskal–Wallis test (independent 
samples median test) and a Mann–Whitney test because the data were not normally distrib-
uted. Diff erences were considered statistically signifi cant when p < 0.05. [13]
RESUlTS
No signifi cant diff erence in the amount of DNA per sample was found between the two 
meshes (Figure 1). No signifi cant diff erence was found between the production of pro-
Figure 1. Amount of DNA per sample
The amount of DNA per sample for each of the two 
meshes is shown. The horizontal bar represents 
the mean amount of DNA. n = 3 donors with three 
samples / donor.
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infl ammatory cytokines by macrophages on Parietex or Parietex Progrip. The pure polyester 
(Parietex) mesh induced a higher amount of all pro-infl ammatory cytokines compared to 
the Progrip mesh, albeit not signifi cant (Figure 2).
For the anti-infl ammatory cytokines the same trend was seen (Figure 3). The pure poly-
ester mesh had a higher mean production of anti-infl ammatory cytokines compared to the 
self-gripping polyester mesh, but this diff erence was not signifi cant. The calculated M1/M2 
index was almost the same for both meshes (Figure 4).
DISCUSSION
To reduce the burden of chronic post-operative inguinal pain (CPIP) and enhance surgical 
handling of meshes manufacturers continue to develop new meshes with diff erent materi-
als, construction and properties. The purpose of this study was to evaluate the biocompat-
ibility of a self-gripping polyester mesh supplemented with self-adhering polylactic acid 
micro hooks to provide an atraumatic tissue adherence of the mesh. Biocompatibility was 
determined by analyzing the production of pro- and infl ammatory cytokines in an already 
proven in vitro model of healthy human primary macrophages 24. To facilitate comparison 
of the Parietex Progrip mesh with a Parietex mesh a relative M1/M2 index was calculated for 
each biomaterial.
Figure 2. Pro-infl ammatory cytokine production 
Shown is the macrophages’ protein production in picogram (pg) for the Parietex and Parietex Progrip mesh. 
Measurement took place 3 days after seeding and culturing the macrophages on the meshes The amount of pg 
protein is corrected for nanogram (ng) DNA per sample. There were 3 samples per donor and 3 diff erent donors. 
The horizontal bar represents the mean production of pg protein per ng DNA.
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The balance between M1 and M2 macrophage reaction plays a critical role in the healing 
and remodeling of injured tissues and acceptance and ingrowth of meshes 25. Mesh pro-
pensity to infl uence the M1 and M2 macrophage response reaction on a constructive way 
depends on the biomaterial composition, e.g. the type of polymer, the material weight and 
dimension, the fi lament structure and pore size. 6,21,26-29 Surgical meshes are mainly made 
of non-absorbable polymers like polypropylene (PP) or polyester (PET). To enhance mesh 
properties PLA was added to a polyester mesh. This synthetic biodegradable polymer was 
fi rst used as biodegradable suture in the 1960s with the purpose to avoid a chronic foreign 
Figure 3. Anti-infl ammatory cytokine production
Picogram protein corrected for nanogram DNA per sample, 3 samples per donor, 3 diff erent donors
Figure 4. M1/M2 index
The percentage of the mean production per cyto-
kine was calculated, followed by dividing the mean 
percentage of M1 cytokines by the mean percent-
age of M2 cytokines per sample. [13]
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body reaction. 30 Although it has been used in surgery for many years now, it has never been 
used before for the construction of surgical meshes.
Meshes combining absorbable and non-absorbable materials mostly elicit a typical host 
response; there is an increased inflammatory reaction with greater macrophage and lym-
phocyte infiltration accompanied by a greatly reduced FBR with limited fibrosis, because the 
absorption of the absorbable fibers reduces the amount of foreign material persisting in the 
host 6. The enhanced infiltration of macrophages and lymphocytes is needed to degrade 
and phagocyte the absorbable material 22. Phagocytosis of implanted biodegradable mate-
rials is enhanced by MMPs that can degrade the implanted material 23 Expression of MMPs 
is promoted by the pro-inflammatory cytokines IL-1β and TNFα suggesting M1 macrophage 
dominance22. Interestingly, no increased pro-inflammatory reaction was seen for the polyes-
ter-polylactic-acid composite self-gripping mesh. Macrophages seeded on the composited 
Parietex Progrip mesh produced a commensurate amount of both pro-inflammatory and 
anti-inflammatory/repair proteins. The FBR was comparable to the reaction elicited by the 
pure polyester mesh reflected in the same M1/M2 index. Junge et all experienced the same 
when investigating the influence of poliglecaprone 25 (Monocryl) supplementation on the 
biocompatibility of a polypropylene mesh. 31
It turned out that the polylactic micro-hooks did not alter the acute response of the mac-
rophages, inducing no extra inflammatory response. Polylactic-acid degrades much slower 
than for instance the polyglycolic -acid and the collagen film of the Parietex Composite™ 
mesh, for which we found in previous research indeed an increased pro-inflammatory 
response 24. Whether this attenuated response also leads to less inflammatory damage to 
tissue and nerves is not clear. At least no reduced levels of CPIP are found for the Parietex 
Progrip mesh 19,20,32. Probably other surgical factors like the dissection, nerve trauma and the 
presence of mesh in the inguinal canal and contacting the nerves play a more important 
role in the development of CPIP. The limited fibrotic reaction that was found for the self-
gripping mesh may help in mesh integration and a reduced foreign body feeling 33. At least 
recurrence rates are reported to be comparable to a sutured mesh.16,34
It is difficult to simulate the complex host response elicited by biomaterials in an in 
vitro model and to translate the results to the in vivo situation. Limitations are the artificial 
circumstances eliminating surgical factors, the monocellular evaluation without other im-
mune cells involved in the FBR like mast cells and fibroblasts. Moreover, we used different 
blood samples which reacted differently to the biomaterials. However this is the same in 
real life and can be used to make sub analysis for specific patient populations like obese or 
diabetics. Although these limitations, an in vitro model gives an indication of the initial FBR 
and allows the comparison of this response between biomaterials. It will help to investigate 
whether some unwanted side effects as chronic postoperative inguinal pain are due to the 
type of mesh implanted or are dependent on other factors like the repair technique.
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To conclude, polylactic-acid micro hooks supplemented to a polyester self-gripping mesh 
does not seem to influence the acute response of macrophages in an experimental model 
using human derived macrophages; the inflammatory cytokine profile is comparable with 
a mere polyester mesh.24
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AbSTRACT
Background
Chronic postoperative inguinal pain (CPIP) is the most common long-term complication of 
inguinal hernia repair. As such procedures are routinely performed, CPIP can be considered 
a significant burden for global health care. Therefore, adequate preventative measures 
relevant to surgical practice are investigated. However, as no golden standard research ap-
proach is currently available, study methods and outcome measures differ between studies. 
The current review aims to provide a qualitative analysis of the literature to point out if 
outcomes of CPIP are valid and comparable facilitating recommendations on the best ap-
proach to prevent CPIP.
Methods
A systematic review of recent studies investigating CPIP was performed, comprising studies 
published in 2007-2015. Study designs were analyzed regarding the applied CPIP defini-
tions, the use of validated instruments, the availability of a baseline score and a minimal 
follow-up of twelve months.
Results
Eighty eligible studies were included. In 48 studies, 22 different definitions of CPIP were 
identified of which the definition provided by the International Association for the Study 
of Pain was most often applied. Of the included studies, 53 (66%) studies used 33 different 
validated instruments to quantify CPIP. There were 32 (40%) studies that assessed both pain 
intensity (PI) and Quality of Life (QOL) with validated tools, 41% and 4% had a validated 
assessment of only PI respectively QOL and 15% lacked a validated assessment. The visual 
analogue scale and Short Form 36 were most commonly used for measuring PI (73%) and 
QOL (19%). Assessment of CPIP was unclear in 15% of the included studies. A baseline score 
was performed by 45% of the studies and 75% had a follow-up of at least 12 months.
Conclusion
The current literature addressing CPIP after inguinal hernia repair has a variable degree of 
quality and lacks uniformity in outcome measures. Proper comparison of study results to 
provide conclusive recommendations for prevention methods for CPIP therefore remains 
difficult. These findings reaffirm the need for a uniform and validated assessment with uni-
form reporting of outcomes to improve the burden that CPIP poses for a significant surgical 
patient population.
111
Uniformity of chronic pain assessment in literature
7
INTRODUCTION
Chronic postoperative inguinal pain (CPIP) is the most common complication following 
inguinal hernia repair, occurring in roughly 20% of patients. 1,2 As inguinal hernia repair is 
a routinely performed surgical procedure, the frequent occurrence of CPIP constitutes a 
significant burden on surgical care. 3 As a result, CPIP has provided a strong incentive to 
optimize preventive and therapeutic strategies, yielding a large amount of investigative 
studies over the recent decades. However Subsequent reviews have been faced with 
significant heterogeneity in study methods and outcomes. The heterogeneity of available 
studies is largely attributable to the varying application of CPIP definitions, different timing 
of post-operative assessment utilizing different measurements and the lack of standardized 
reporting of outcome results. Such heterogeneous data may be considered insufficient as a 
basis for consensus which needs uniform and validated study designs to ensure adequate 
scientific evidence for clinical decision-making. 4. As a solution, the working group The 
Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) 5 and 
the International Association for the Study of Pain (IASP) 6 recommended core outcome 
domains to be considered in the development of studies investigating CPIP. These core 
domains are comprised of pain intensity (PI), consequences of chronic pain on physical 
and emotional functioning and the participants’ rating of overall improvement. In addition, 
these core outcomes should be measured prospectively with a minimal follow-up of 1 year 
using two or more standardized assessment tools.
Furthermore, the National Institute for Health and Clinical Excellence (NICE) has empha-
sized the importance of utilizing prospective study designs to address these core outcome 
domains, in order to standardize definitions and assessment methods of pain. 7 The aim of 
the current review is to investigate whether the recommendations made in 2005 by the 
IMMPACT, IASP and NICE have led to improved uniformity and quality in the design of stud-
ies focusing on CPIP to a degree that allows the formation of conclusive recommendations 
to reduce the onset of CPIP.
METHODS
Search strategy
The literature search was performed using several databases, which were Medline in 
PubMed, Embase and the Cochrane Library. The following mesh terms were combined: 
‘hernia, inguinal’, ‘chronic pain’, ‘herniorraphy’, ‘Lichtenstein’. To ensure that the search would 
yield a complete overview of current literature, the MeSH terms were used in conjunction 
with free text word combinations as this search strategy would also cover papers without 
appropriate MeSH terms and papers not yet fitted with MeSH terms. The search was re-
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stricted to articles published in the English language from 2007 to 2015 to obtain the most 
recent studies that were relevant to the aim of this review.
Inclusion criteria
Studies
Prospective studies and study protocols with the Lichtenstein method as the referring tech-
nique were included, irrespective of the application or method of randomization. Also, to 
suit the purpose of this review, studies were included regardless of sample size, publication 
status and whether it concerned single or multi centered studies.
Patients 
As this study focuses on the adult patient population, all patients aged 18 years and 
above were included. All types of hernia (primary or recurrent, uni- or bilateral) that were 
investigated were included for both adult male and female populations to ensure broad 
applicability of our results in a large and diverse patient population in clinical practice.
Interventions 
Correction of an inguinal hernia irrespective of the surgical technique
Outcomes 
CPIP is among the primary or secondary outcomes
The review process was performed in two steps. First, all abstracts were subjected to the 
eligibility criteria, consulting the full-text papers in case of doubt about whether the study 
met these criteria. Next, all full-text papers of the selected abstracts were read and analyzed 
in full to make a final decision about inclusion.
Outcomes of interest
According to the recommendations of the IMMPACT, IASP and NICE all included studies 
were scored for the presence of:
(1) formal definition of CPIP
(2) validated measurement of both PI and the effects of CPIP on daily functioning or QOL
(3) duration of follow up of at least 12 months
(4) baseline score: preoperative measurement of PI and QOL
One point was assigned to a study for the availability of each of the above mentioned as-
pects, after which each study was assigned an overall methodological quality score ranging 
from 0 to 4.
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RESUlTS
Using the strategy described above, the search yielded 234 hits (see PRISMA fl owchart in 
Figure 1). After applying the search limitations, 109 articles remained eligible for inclusion. 
Following critical review of these full-text articles, 29 articles were excluded for not meeting 
the inclusion criteria. The reasons for exclusion at this stage were retrospective study design, 
the article being a review or comment, a lack of CPIP among the primary or secondary 
outcomes. Also, studies reporting the long term follow-up of another included study were 
considered redundant and were therefore excluded.
Following critical review, eighty studies fi tted the eligibility criteria. Among these studies, 
52 articles described RCT’s and 38 studies had a comparative study design (Table 1). Most 
studies investigated the Lichtenstein technique using diff erent meshes (n=10), fi xation 
methods (Progrip mesh n=13, glue n=10), analgesia (n=3) and method of nerve handling 
(n=5). Other studies compared the Lichtenstein technique to pre- or retroperitoneal mesh 
placement: totally extra peritoneal (TEP) repair (n=12), Prolene Hernia System (PHS) repair 
(n=4), plug and patch (n=4), Kugel (n=2), trans inguinal preperitoneal (TIPP) repair (n=1), 
transabdominal preperitoneal (TAPP) repair (n=5) . Seven studies compared Lichtenstein 
hernioplasty with non-mesh techniques: Maloney Darn repair, (MDR, n=2), Shouldice (n=1), 
Desarda (n=1), suture repair (n=2). In 55 studies, CPIP was the primary outcome measure, in 
the other studies CPIP was among the secondary outcomes.
Figure 1. PRISMA fl ow chart
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1 CPIP Definition
A definition of CPIP was lacking in 31 (39%) studies (Tabel 1). 8-38 In the other 49 (61%) stud-
ies, a total of 22 different definitions of CPIP were identified (Table 2). Almost half (n=23) 
of these studies applied the definition provided by the IASP, which is “chronic pain is pain 
Table 2. Overview of the different definitions of Chronic Post-operative Inguinal Pain (CPIP) used in the in-
cluded studies
First author Definition of CPIP
n=49 (61%)
Anadol ((52), Beldi (43), Bellows (53), 
Chatzimavroudis (59), Dhankhar (60), 
Eklund (32, 48), El-Awady (46), Fricano 
(49), Honingman (41), Jeroukhimov (61) , 
Kapischke (50), Kim Fuchs (55), Koning (56), 
Malekpour (44), Myers (51), Nienhuijs (42, 
62), Quijn (57), Sanders (47), Sadowski (54), 
Singh (58), Staal (45) (n=23)
IASP: any VAS lasting >3 months
Andresen (74)
Pain-related impairment of function at 6 months defined as AAS > 8.3
Pain that impairs daily function at the 12-month
Jain (69), Ripetti (75)
Proportion of patients with pain that impairs daily function at 12 
months
Smietanski (63, 65, 90) Pain lasting >12 months (Kehlet)
Caliskan (64) Pain lasting >1 months
Ruiz-Jasbon (67) Pain at 36 months
Pedano (72) Invalidate pain > 3 months
Yilmaz (83) VAS >0 at 4 months
Campanelli (25), Jorgensen (81) VAS >30 at 12 months
Kurmann (85)
VAS as ≥30 in any quality (at rest, lying, walking, climbing stairs, and 
bending over) at 3 months 
Garcia Urena (77) VAS >3 at 3 and 6 months
Bochicchio (84) Any VAS  at 3 and 12 months
Kingsnorth (79) VAS 45/150 lasting >3 months
Shen (80) moderate or greater pain (VAS > 4) in the inguinal area at 3 months 
Belyansky (76) CCS >1 lasting >3 months
Kucuk (70) Pain lasting >2 months and requiring painkillers
Nikkolo (88, 89) Pain at rest at 6 months
Paajanen (78) VAS >2 lasting >3 months
Paajanen (82) VAS > 3 at 12 months
Reinpold (71) Pain once a fortnight lasting >6 months
Szopinski (73) Moderate or strong pain lasting >6 months
Veen (68) Pain interfering with daily activities
IASP = International Association for the Study of Pain; VAS = Visual Analogue Scale; AAS = Activities Assessment 
Scale;  CCS = Carolina Comfort Scale;  > = more than
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that persists beyond three months post-operatively”. 39-62 The remaining half (n=26) used 
multiple definitions of CPIP, which can be categorized and summarized as follows. First, 
there was heterogeneity in the post-operative time period after which pain was classified 
as chronic. This “chronic” timeframe ranged between 1 and 36 months. 63-67 Second, some 
studies included the quantitative factor pain intensity in their definition of CPIP, which was 
either expressed using descriptive terms 68-75, a visual analogue scale (VAS) score or a QOL 
score 31,76-85.
In addition to incorporating a definition of CPIP, 31 (39%) studies provided a categoriza-
tion of pain severity (Table 3). In half of the studies, the categorization consisted of reporting 
the effect of CPIP on daily life using nine different validated or non-validated criteria (Table 
III). 33,40,48,52,58,61,62,68,73,79,86 The remaining studies used a categorization of pain severity based 
on visual or numerical analog scale measurements (VAS or NAS). 8,10,19,22,23,50,56,71,73,81,87-89 The 
subsequent categorization of pain intensity was highly heterogenic (Figure 2). Some studies 
incorporated a minimal pain intensity score to distinguish between clinically relevant or 
minor CPIP. 14,31,71,74,76
Chapter 7
Figure 2: Categories of CPIP based on VAS score
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121
Uniformity of chronic pain assessment in literature
7
Table 3. Overview of the different definitions and categories of pain severity 
First author Categories of CPIP
Anadol (52)
“intolerable pain” =  “intractable” or “hard to live with” and those pain which 
requires pain medication and/or medical consultation 
Szopinski (73)
Sheffield scale: 
0 = no pain
1 = no pain at rest but it appears during movement
2 =  temporary pain at rest and moderate during movement
3 = constant pain at rest and severe during movements
Eklund (40, 48), Smietanski (90)
mild = occasional discomfort or pain not interfering with daily activities
moderate = discomfort or pain occasionally interfering with daily activities
severe = discomfort or pain interfering with daily activities
Veen (68) pain and discomfort whether or not interfering with daily activity
Lionetti (33)
Cunningham’s criteria:
Mild = occasional pain or discomfort that did not limit activity, with a return to 
pre-hernia lifestyle
Moderate = pain preventing return to normal preoperative activities (inability to 
continue any sports or to lift objects without pain)
Severe = pain constantly or intermittently present but so severe as to impair 
normal activities, such as walking.
Jeroukhimov (61)
Mild = occasional pain or discomfort that did not limit daily activity and did not 
require pain medicine.
Moderate = pain that interfered with a return to normal everyday activity with 
rare analgesic requirement.
Severe = pain that incapacitated the patient, occurred at frequent intervals, or 
interfered with everyday activities with a frequent need for painkillers. 
Nienhuijs (62)
Pain was graded into non/mild/moderate and severe using a Verbal Discriptor 
Scale (VDS) for different aspects of life
Kingsnorth (79), 
Sanders (47), Singh (58)
Surgical Pain Scale: measures pain while at rest, during normal activities, 
during work or exercise, and pain unpleasantness.
Belyansky (76) relevant pain = CCS>1
Ruiz-Jasbon (67), Sadowski (54)
pain yes or no in different situations according to Inguinal Pain Index: if yes a 
score on a VAS was asked
Andresen (74) moderate to severe pain = VAS 4-10
Campanelli (25) relevant pain = VAS>30 
Dalenbäck (14) severe = VAS >70
Champault (8), Demetrashvili (23) mild = VAS <30, moderate = VAS <50, severe or debilitating = VAS >50
Champault (22) , Jorgensen (81) mild = VAS 1–30, moderate = VAS 31–60,  severe = VAS>60
Nikkolo (88, 89) mild = VAS 1-10, moderate  = VAS 11-50, severe = VAS >50
Reinpold (71)
not relevant CP: mild CP =  VAS 1-3,
relevant CP: moderate CP= VAS 4–6, strong CP= VAS 7–9, very strong CP =VAS 10
Karakayali (10, 19), Koning (56) mild = VAS 1-30, moderate = VAS 40-70,  severe = VAS>70
Szopinski (73) moderate = VAS 30-54, strong = VAS>54
Kapischke (50) low to medium = VAS 0-40; medium to strong = VAS >40 
Lauscher (12) weak = NAS 1-3, moderate/severe = NAS>3
VAS - Visual Analog Scale, in the studies ranging from 0=10 or 0=100; NAS = Numeric Analog Scale; CCS = Caro-
linas Comfort Scale; CP= chronic pain
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Table 4. The number of studies that uses validated or non-validated assessment tools to measure CPIP
Type of assessment tool used Number of studies ( %)
No information given 8 (10%)
Non validated questionnaire: separated questions, written or by interview 19 (24%) 
As a single measurement tool 4 
In combination with a validated pain intensity score 12 
In combination with a validated pain intensity and QOL score 3 
Only validated questionnaire(s) or pain intensity scale (number of different tools n = 30) 53 (66%)
 QOL = quality of life;
Table 5. Tools used to measure CPIP
Shortening Full name Number of studies it is used in
AAS Activities Assessment Scale 3
BPI Brief Pain Inventory 1
CCS Carolinas Comfort Score 2
DHD Danish Hernia Database questionnaire 1
FAT Functional Ability test 1
FIS Functional Index Score 2
IPQ Inguinal Pain Questionnaire 4
MPQ Mc Gill Pain Questionnaire 1
NAS Numeric Analog Scale 1
PAS Pain Assessment Survey 1
PDI Pain Disability Index 1
PIQ-6 Pain Impact Questionnaire
PIC Pain Intensity Scale 1
PPT Pin Prick Test 1
PMD Pain Matcher Device 2
SF12 / SF12v2 Short Form 12 / Short Form 12 version 2 2
SF36 / SF36v2 Short Form 36 / Short Form 36 version 2 16
SF-6D Short Form – 6 Dimensions 1
SHS Short Health Scale 2
SPS Surgical Pain Scales 3
ShS Sheffield Scale 1
SS Sergel Score 1
VAS-100mm Visual Analog Scale 0-100mm 57
VAS-150mm Visual Analog Score 0-150mm 1
VDS Verbal Discriptor Scale 1
VRM Verbal Rating Model 1
VRS Verbal Rating Scale (0-100) 3
VRS-4 Verbal Rating Scale (0-4) 1
WBF Wong-Baker Faces Rating Scale 1
FF von Frey Filaments 1
a validated questionnaire ‘ 3
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2.1 CPIP Assessment Tool(s) 
Fifty-three (66%) studies used only validated instruments for the assessment of CPIP. How-
ever, among these studies, 33 different validated instruments were identified (Table 4, 5, 6). 
11,13,14,17,19,21,26,28,29,32,36,38,41,43,45,47,48,51,53,56-65,79,90
In 19 (24%) studies, non-validated instruments were used. 10,18,20,27,30,33-35,40,42,44,49,50,52,54,65,68,71,77,82 
The majority of these studies described these instrument using non-specific phrases such 
as ‘a questionnaire was used’ or ‘patients were interviewed’. Of these studies, fifteen utilized 
a non-validated instrument in conjunction with a VAS 10,30,33-35,40,42,44,50,52,71,77,82, VRS 49, Inguinal 
Pain Questionnaire (IPQ) 54, or Functional Index Score (FIS) 40.
In 8 (10%) studies there was no information provided about how data was collected 
9,15,16,37,70,72,75.
Thirty-one (39%) studies provided definitions of the severity of CPIP (Table 3). Fifteen 
studies defined pain severity in terms of pain intensity according to the score on a Visual 
analog scale (VAS) or numerical analog scale (NAS). The categories of pain intensity based 
on VAS scores were heterogenic and thus not comparable.
2.2 Validated assessment of both pain intensity and QOl
Thirty-two (40%) studies had a validated assessment of both PI and QOL, 
11,14,19,20,22,24,29,31,34,38,40,41,43,45,48,53,54,56,58,60,62,65,67,73,74,76,84,86-90, 33 (41%) respectively 3 (4%) studies there 
was only a validated assessment of PI 8,10,13,17,21,23,25,26,28,30,33,35,36,42,44,47,49,50,52,59,61,63,69,71,77,78,80-83,85 or 
QOL 46,51,57.
Table 6. Tools used to assess QOL and or pain intensity
Quality of Life (QOL) or
Functional assessment
Pain Intensity (PI) QOL + PI
Activities Assessment Scale Numeric Analog Scale Carolinas Comfort Score
Activity Restriction Questionnaire Pain Intensity Scale Brief Pain Inventory
Danish Hernia Database questionnaire Pain Matcher Device Mc Gill Pain Questionnaire
Functional Ability Test Pin Prick Test Short Health Scale
Functional Index Score Surgical Pain Scale Inguinal Pain Questionnaire
Pain Disability Index Sheffield Scale
Short Form 12 / 12-2v Sergel Score
Short Form 36 Visual Analog Scale 0-100mm
Short Form – 6 Dimensions Visual Analog Score 0-150mm
Pain Impact Questionnaire Verbal Rating Model
Verbal Rating Scale
Verbal Discriptor Scale
Wong-Baker Faces Rating Scale
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In 12 (15%) studies there was neither a validated assessment of PI nor QOL. 
9,15,16,18,27,37,55,68,70,72,75
The majority of studies investigating PI used VAS measurements, while QOL was most 
often examined using the SF36 questionnaire. (Table I and VI). Of the instruments that 
incorporate the assessment of both PI and QOL, the Inguinal Pain Questionnaire (IPQ) was 
used most.
3 Duration of follow-up of at least 12 months 
The duration of follow-up ranged from 6 weeks to 96 months. Sixty (75%) studies had a 
follow-up of 12 months or longer with a median of 12 months (Table I).
4 Availability of a baseline score
A baseline score was performed by 45% (36/80) of the included studies (Table I).
Table 7. Methodological Quality Score
overall 2007 - 2010 2011 - 2015
N % N % N %
80 33 47
4 points 9 11% 5 15% 4 9%
100% 56% 44%
3 points 21 26% 2 6% 19 40%
100% 10% 90%
2 points 30 38% 15 45% 15 32%
100% 50% 50%
1 point 18 23% 11 34% 7 15%
100% 61% 39%
0 points 2 2% 0 0% 2 4%
100% 0% 100%
P=0.005
The methodological quality and comparability of the literature on CPIP was analyzed by scoring the included 
studies for:
(1) CPIP is defined thereby making use of standard internationally practiced criteria
(2) both PI and effects of CPIP on QOL are measured thereby making use of validated assessment tools
(3) sufficient follow up of at least 6 months
(4) availability of a baseline score e.g. preoperative measurement of PI and QOL
One point each was assigned for the availability of one the above mentioned aspects and each study was as-
signed an overall methodological quality score ranging from 0 to 4.
* Chi squared test
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Methodological quality score
The full amount of 4 points was scored by 11% of the studies, 26% scored 3 points, 38% 
scored 2 points, 23% scored 1 point and 2% scored 0 points (Table 7). When comparing 
the periods 2007-2010 and 2011 until to date there is a significant improvement of the 
Methodological quality score (P=0.005). The highest score was for the criterion to have a 
minimum of 12 months of follow up, second highest was the availability of a CPIP definition, 
on the third place was the performance of a baseline measurement and the worst was 
scored on the availability of a validated assessment of both PI and QOL.
DISCUSSION
The results from this review demonstrate that the current scientific literature investigating 
the management of CPIP after inguinal hernia repair is flawed due to lack of adherence 
to, and existence of commonly accepted definitions of the primary outcome, standards in 
study methodology and instrument tools. We found that, although the majority of studies 
provided similar definitions of CPIP, the variable interpretation of such definitions does not 
enable adequate comparisons, opposes uniformity and therefore obstruct evidence-based 
clinical decision making. Similarly, despite the fact that the majority of included studies did 
use a validated assessment tool to quantify CPIP, we found that a total of 33 different tools 
were used among these studies. The measurements of PI and QOL, which are both included 
in the recommendations of the IMMPACT and IASP, were performed using non-validated 
tools in a majority of studies. Furthermore, the majority of these studies provided no pre-
operative baseline measurements of CPIP which clouds the interpretation of outcome 
findings.
Despite the efforts put forth by the scientific community, it appears that the current sci-
entific literature about CPIP is heterogeneous to a degree that limits meta-analysis. Interest-
ingly, the clinical relevance of this conclusion is not limited to the current state of scientific 
literature. Similar conclusions were drawn by Kehlet et al, who stated that no proper recom-
mendations to prevent or treat CPIP could be made based on the sparse scientific evidence 
available over a decade ago. 4. Based on their findings, they issued a call for uniformity and 
provided recommendations for an optimal study design as a solution for the heterogeneity. 
A more recent study published in 2007 by Hanswijck de Jonge et al. concluded that the 
measurements of pain and discomfort scores remained highly heterogeneous as studies 
evaluated CPIP by different types of instruments of varying quality and accuracy. 91
Most of the included studies reported CPIP as the primary outcome. At a fundamental 
scientific level, the primary outcome of a study is the outcome parameter to be measured 
and compared, either to the control group in a comparative study or to results from the 
literature in non-comparative studies. Such a comparison to literature requires the unam-
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biguous definition of the primary endpoint to provide conclusions of scientific and clinical 
value. To further enhance the comparability of scientific literature, it is of great importance 
to comply with standardized international definitions and to adhere to accepted categoriza-
tions of outcome measures. In the case of current CPIP literature, we found that 39% of 
studies lacked a definition of the primary outcome. When a definition was provided, it was 
often a non-standardized as we were able to identity 22 different CPIP definitions across 
the remaining 49 studies (Table II). The IASP definition of chronic pain was most frequently 
used, which states that ‘chronic pain is any pain that persists beyond the normal tissue heal-
ing time usually taken to be 3 months’ 39. The other, non-standardized definitions diverged 
with respect to duration, intensity and severity. It appears that expert opinions disagree 
regarding the cut-off points between acute pain and chronic pain. This could be expected, 
considering that the IASP also uses different definitions for chronic pain and persistent post-
surgical pain (PPSP), which is defined as ‘pain that develops after a surgical intervention and 
lasts at least two months excluding other causes for the pain’ 6. Aasvang and Kehlet argued 
that given the possibility of an ongoing inflammatory reaction to a prosthetic mesh, CPIP 
should be measured at least six months postoperatively. 92 Others used a minimum duration 
of twelve months based on an earlier article of Kehlet et al 4.
The definition of CPIP provided by the IASP is based solely on a time factor as it regards 
discomfort to be pain scoring any VAS above zero. Alternative definitions incorporated 
a pain intensity factor in their CPIP definition. For example, such definitions state that a 
patient needs to express at least a VAS score of 2 or 3 on a scale of 10 to be considered 
as painful. Others added descriptive term of pain severity in their CPIP definition (Table II) 
such as discomfort or pain happening once a fortnight, requiring painkillers or interfering 
with daily activities. These different and seemingly arbitrary thresholds of pain severity and 
duration in the various definitions of chronic pain influence the incidence and prevalence 
rates of chronic pain and hinders comparisons between studies. In a recently published in-
ternational expert consensus article, CPIP is defined as ‘chronic inguinal post-operative pain 
that still exists and affects daily life six months post-operatively’.93 However the Herniasurg 
Group, working on the World Guidelines for Groin Hernia Management, is now proposing to 
modify the IASP definition to include only chronic pain that is present from 3 months after 
surgery and which lasts beyond 6 months after surgery.
To generate high-quality evidence for the best preventive and treatment strategies for 
CPIP, it is imperative to use validated scales. To further enhance the comparability of scien-
tific studies, these scales are ideally standardized and clearly described in the manuscript. 94 
Since 33 different instruments could be identified among the included studies, it seems that 
consensus about the optimal instrument for the assessment of CPIP is still lacking.
Several pain assessment tools have been developed to measure different aspects of 
pain. Pain intensity is mostly measured using verbal rating scales (VRS), numerical rating 
scales (NRS) and visual analog scales (VAS). 95 In this review, we found that the VAS was 
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predominantly used (73% of studies). However, these PI scales only provide a global 
estimation of a patient’s experience of pain, without considering all relevant aspects and 
consequences of chronic pain. To elaborate, chronic pain has a major impact on physical, 
emotional, and cognitive function. Furthermore, chronic pain can negatively affect patients’ 
social life and their ability to work and secure an income which also has economic implica-
tions that extend beyond health care. 96 The importance of identifying the repercussions 
of chronic pain as perceived by the patient was demonstrated by Fredheim et al. 97 They 
found that patients with non-cancer related chronic pain reported a QOL that was lower 
when compared to the QOL of terminal cancer patients. IMMPACT and Kehlet et al therefore 
emphasized that, in order to perform a meaningful assessment of chronic pain, it is required 
to utilize quantitative measurement tools in conjunction with multidimensional qualitative 
tools like health-related QOL instruments to adequately assess the impact of chronic pain. 
4,5 The Medical Outcome Survey Short-Form-36 (MOS SF-36 or SF36) is generally considered 
to be the gold standard in QOL measurement. The advantage of the generic SF36 is its 
broad implementation as it is well known by regulatory bodies and physicians. In addition, 
the SF36 is suitable for comparing changes in QOL between different diseases and treat-
ments. However, some authors including Heniford et all argue that a disease-specific QOL 
measure is preferable to assess the impact of CPIP on QOL and patient satisfaction. 98 In this 
review, four hernia-specific QOL measures were identified among eight studies: the Carolina 
Comfort Scale (CCS) 76, the Inguinal Pain Questionnaire (IPQ 48, Activities Assessment Scale 
(AAS) 53 and a questionnaire based on the Danish Hernia Database (DHD). 99 Some studies 
used rating scales like the VAS to measure QOL. 62 There are also questionnaires available 
that incorporate assessment of PI (sensory dimension) and the degree of interference of 
chronic pain with aspects of daily life (reactive dimension). Examples of such questionnaires 
are the general McGill Pain Questionnaire, Short-Health Scale, Brief Pain Inventory (BPI) 100 
and the hernia specific CCS and IPQ. Besides questionnaires, objective methods like pain 
evoked responses and quantitative sensory testing are gaining popularity but are not yet 
utilized on a regular basis. Deciding upon the appropriate questionnaire to use will likely 
remain challenging as long as consensus is lacking.
The majority of reviewed studies lacked a baseline measurement of PI and QOL. This 
is unfortunate, as baseline measurements are necessary for meaningful interpretation of 
postoperative results. Furthermore, preoperative pain is a known risk factor for develop-
ing CPIP and therefore holds clinical relevance that might be undermined when it is not 
incorporated into studies investigating CPIP. 101 
To reiterate, the literature concerning treatment and prevention of CPIP is highly hetero-
genic and inconsistent. Since a consensus measure is the only way to bring about more 
standardized and comparable results, CPIP literature will benefit from a common standard. 
This common standard should include one clear definition for the outcome measure CPIP, 
incorporating pain duration, pain intensity and the effects of chronic pain on daily activities. 
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Also, a common study methodology is needed that uses well-defined standard outcome 
parameters which are evaluated with validated instruments and a sufficient period of 
follow-up. Whether certain types of measurement tools should be recommended to further 
improve the uniformity among studies is open for discussion, for example by the Hernia-
Surge Group that is currently designing a global guideline for the management of groin 
hernia. We recommend an easy to use, hernia-specific score incorporating assessment of 
both PI and QOL. Finally baseline measuring should become common practice and follow-
up be done on standardized time points.
However, without an ambitious implementation plan designed to reach targeted groups, 
the impact of a common standard could be disappointing. Global recognition and aware-
ness is essential and may be performed through the world wide hernia societies.
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In Chapter 1 the subject of the thesis, chronic pain after common operations, is introduced. 
Common operation such as laparotomy, laparoscopy and inguinal hernia surgery can cause 
high rates of post-operative chronic pain leading to functional impairment, reduced quality 
of life and social- and economic consequences. These consequences together with high in-
cidence rates makes that chronic post-operative pain must be considered as a major health 
problem. The exact cause of the pain is not always clear and both patient- and surgical 
related factors are of influence.
PART 1 CHRONIC PAIN AFTER ABDOMINAL SURGERY: ADHESIOLYSISYES
In the first part of the thesis chronic pain after abdominal surgery judged to be caused by 
adhesions is addressed
Chapter 2 reports the long term results of a randomized placebo controlled trial assess-
ing the benefit of laparoscopic adhesiolysis in 100 patients with chronic abdominal pain 
attributed to adhesions. After 12-year follow-up patients in the adhesiolysis group were 
significantly less often free of pain (RR=1.30), had a higher intake of analgesics (RR=1.20), 
consulted medical specialists more often (RR=1.33) and had a higher rate of additional 
surgery (RR=1.67) because of persisting pain. Thus it was concluded that laparoscopic 
adhesiolysis was less beneficial than laparoscopy alone in the long term and that there is 
a powerful and long lasting placebo effect of laparoscopy. Since adhesiolysis is associated 
with an increased risk at surgical complications, avoiding this treatment will result in less 
morbidity and health care costs.
PART 2  CHRONIC PAIN AFTER INGUINAL HERNIA REPAIR: A SELF-GRIPPING 
MESH
In the second part studies are presented on the results of a self-gripping mesh for Lichten-
stein repair of primary inguinal hernias in adult patients.
Chapter 3 describes the 5 year results of the patient cohort of 83 patients that was used 
as a pilot study for the HIPPO trial which compared a self-gripping mesh with a sutured 
mesh for the Lichtenstein hernioplasty (Chapter 4). CPIP was defined as any VAS score 
above zero lasting more than three months post-operatively. After a median follow up of 30 
months 14.6% of patients in the self-gripping mesh group (n=41) reported CPIP compared 
to 23.8% in the suturing mesh group (n=42). After a median follow-up of 67 months this was 
reduced to 4.8% respectively 9.8%. It was also asked whether CPIP affected daily life. After 30 
months this was true for 1 patient in the self-gripping mesh group (2.4%) and 3 patients in 
the sutured mesh group (7.1%). After 67 months this was reduced to 0% respectively 2.4%. 
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Severe pain (VAS>70) was only seen in the suturing mesh group. Two patients in the self-
gripping mesh group and one in the sutured mesh group experienced a recurrent hernia. 
The operating time was shorter for the self-gripping mesh, because no time was needed 
to suture the mesh. This was the only outcome that different significantly between both 
groups.
Chapter 4 presents the results of the HIPPO trial. This randomized double blinded multi-
center trial compared a self-gripping mesh with a sutured mesh for the Lichtenstein hernio-
plasty. Results are based on 331 patients that were followed for 2 years. It turned out that 
the self-gripping mesh had comparable rate of CPIP, recurrence and other post-operative 
complications compared to the sutured mesh. The overall incidence of CPIP after 24 months 
was 4.6% and for recurrence rate this was 2.4% for the Progrip mesh and 1.8% for the sutured 
mesh. Patients reported significantly better pain and quality of life scores throughout the 
follow up period. The only significant difference that was found was the mean duration of 
surgery was 17% reduced for the self-gripping mesh.
In Chapter 5 the long term results of the self-gripping mesh were further explored with 
a systematic review and meta-analysis of 10 RCTs enrolling 2541. Mean follow-up was 24 
months (range 6-72 months). It had to be concluded that the self-gripping mesh is no 
solution to lower the incidence of CPIP; it has comparable results to a sutured mesh regard-
ing the incidence of CPIP, recurrence and other late morbidity. However conclusions on 
long-term results are still based on relatively small patient numbers due to heterogeneity 
in CPIP definition, assessment, and presentation of outcome. The main advantage of the 
self-gripping mesh is its efficiency with consist significantly reduced operation times.
Chapter 6 presents the results of an in vivo study examining the reaction of macrophages 
to the self-gripping mesh which contains additional polylactic acid micro hooks on its lower 
surface. It turned out that the macrophages produced comparable amounts of pro- and 
anti-inflammatory cytokines to the self-gripping mesh and a standard mesh without the 
polylactic acid. Therefor it was concluded that polylactic acid does not have negative effects 
on mesh biocompatibility.
PART 3 CHRONIC PAIN: ASSESSMENT IN LITERATURE
In the third part the quality and comparability of the literature on chronic pain after ingui-
nal hernia surgery is reported
Chapter 7 reports a systematic review addressing the quality and uniformity of recent 
studies investigating CPIP. Eighty eligible studies were included. Only half of the studies 
provided a definition of their primary outcome CPIP and 22 different definitions of CPIP 
were identified. The chronic pain definition of the International Association for the Study of 
Pain was most often applied. Only 66% of the studies used a validated tool to evaluate CPIP 
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and 33 different tools were identified. The visual analogue scale and Short Form 36 were 
most commonly used for measuring PI (73%) and QOL (19%). When investigating chronic 
pain it is important not only to quantify CPIP but also to explore the repercussions for the 
quality of life. This was done by only 40% of the studies. A baseline score was performed by 
45% of the studies and 75% had a follow-up of at least 12 months. It was concluded that the 
current literature addressing CPIP after inguinal hernia repair has a variable degree of quality 
and lacks uniformity in outcome measures. Proper comparison of study results to provide 
recommendations for prevention methods for CPIP therefore remains difficult.
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Acute postoperative pain is followed by CPP in 10–50% of individuals after common opera-
tions and can be severe in 2-10% of these patients.1 CPP must be regarded a major health 
problem because of its negative effect on QOL, social relationships and employment and 
because of its micro- and macro-economic drawbacks.
Whether CPP after abdominal surgery may be caused by adhesions is questionable. More 
certain is the inefficiency of laparoscopic adhesiolysis as a treatment method. It may reduce 
pain in the initial phase after treatment but there is no evidence for long-term efficacy of 
adhesiolysis for CPP (Chapter 2).2,3 Other drawbacks of laparoscopic adhesiolysis are the 
high rate of incompleteness of adhesiolysis especially in the case of so called ‘cocoon’ adhe-
sions and the risk of bowel injury. Furthermore, it is important to realize that the develop-
ment of CPP is multifactorial, influenced not only by surgical factors but also by physical, 
psychological, genetic and social factors. Examples of patient related risk factors are young 
age, female gender, expectations, lower preoperative optimism, anxiety for the operation 
and ineffective coping mechanisms.4-6 In addition people who already experience chronic 
pain preoperatively are at greater risk to develop CPP after surgery. This may be due not only 
to genetic susceptibility or psychosocial characteristics, but also to changes in the nervous 
system.1,7 It is hypothesized that persistent nociceptive input from injured peripheral nerves 
causes long lasting neuroplastic changes to the central nervous system with reduction in 
thresholds, amplification of responses and nervous hyperexcitability. This central sensitiza-
tion increases the risk of CPP.1 All these factors may explain why some patients develop CPP 
and others do not. A good illustration is given by Aasvang et al. He showed by quantitative 
sensory testing (QST) that sensory dysfunction as a result of nerve damage is apparent in 
many patients after groin hernia repair, both patients with and without CPP. 7,8
The second part of this thesis focusses on chronic postoperative inguinal pain (CPIP) after 
inguinal hernia repair. Tension-free mesh techniques have revolutionized the procedure, but 
CPIP is still a challenging complication. Nerve injury is often cited as the most prominent 
causative factor. One way by which nerves can be damage is mechanical entrapment by 
devices used to fixate the mesh. 5 Every surgeon is aware of the risk of nerve entrapment in 
fixation sutures which causes the patient to have immediate severe postoperative pain. Rapid 
reoperation to release the entrapped nerve gives instant pain relief and when performed 
under local anesthesia the patient can sometimes exactly tell the surgeon which stitch has 
to be removed. In addition these penetrating sutures, staples and tacks may cause tension 
at anchor sites, additional foreign body reaction and periostitis when placed through the 
periosteal layer of the pubic bone.9,10 Despite all this the atraumatic self-gripping mesh did 
not turn out to reduce the incidence of CPIP; the distribution of pain severity and QOL scores 
are comparable with a standard sutured mesh (Chapters 2-4). This should be interpreted 
through surgical- and patient- related factors as well as methodological factors.
Starting with the surgical factors it can be argued that the micro hooks are also inflicting 
trauma to the underlying tissues and nerves. This may be true, only that the ilioinguinal and 
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iliohypogastric nerve are protected by an investing fascia of the internal oblique muscle 
and a layer of areolar connective tissue. The genital branch of the genitofemoral nerve is 
covered by the deep cremasteric fascia. The micro hooks penetrate the tissue for 0.5mm 
which is not enough to penetrate the protecting perineural tissue, which of course should 
be left intact during dissection. A second point of discussion is that not all surgeons imple-
menting the self-gripping mesh perform a truly sutureless procedure, because of concerns 
about recurrence. These concerns may be induced by the experience that the micro hooks 
are less sticking to the connective tissue (overlying the pubic bone: the area of a medial 
recurrence) compared to the muscle tissue. Thereafter extra suture fixation is in line with 
the recommendations made by Philipe Chastan. This French surgeon was involved in the 
development of the Progrip mesh and the first to publish his experiments with the Progrip 
mesh. He recommended surgeons to place one absorbable stitch at the pubic tubercle if 
concern exists for adequate overlap inferomedially to prevent recurrent hernia. Others have 
taken over this recommendation and because the surgeons participating in the HIPPO trial 
were trained by Chastan during a masterclass, this extra stitch was allowed to be placed 
in the trial protocol. However there are concerns about the effect of the extra stitch in this 
neuralgic position. Regarding our own RCT (Chapter 4) it was known that two participating 
surgeons as a rule placed this extra stitch in all patients regardless of the size or location of 
the hernia. We did not found increased pain levels or CPIP rates for the patients operated by 
these two surgeons. Of the RCTs included in the meta-analysis (Chapter 5) some surgeons 
consistently did not place the extra suture whilst others recommended case by case use of 
additional suture fixation in the self-gripping mesh group. None of the studies performed 
subgroup analysis whether the stitch induced more CPIP in patients. A retrospective analysis 
by Kohler et al of the Herniamed register did not show a correlation between the extra 
medial stitch and CPIP rates in more than 800 cases. The same applied to recurrence rates.11 
From this it may be concluded, that although seemingly of no influence on CPIP rates, it 
could be recommended to avoid the single stitch in this neuralgic place.
The Adhesix mesh (Bard, USA) is another concept of self-gripping meshes. In contrast 
to the Progrip mesh it is not based on mechanical fixation, but it has a synthetic adhesive 
coating made of polyethylene glycol (PEG) / polyvinylpyrolidone (PVP) and activated by 
moist tissue. Only one clinical trial on AdhesixTM mesh has been published and reported 
promising results without recurrences after Lichtenstein repair, but follow up was only three 
months. 12 A retrospective study with a follow up of three year reported 7% of patients 
with CPIP. 13 There are no RCTs comparing the Progrip and Adhesix mesh. Gruber-Blum et 
al compared both self-gripping meshes in an animal experimental model and showed a 
significantly higher dislocation tendency for the Adhesix mesh compared to the Progrip 
mesh. The reason for this was not clear and requires further investigation. 14 
How about other non-traumatic fixating devices like fibrin sealant, n-butyl-2 cyanoac-
rylate (NB2C) glues or the self-adhesive mesh? The present literature on the effect of glue 
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versus sutures on the rate of CPIP is not very conclusive. There are five meta-analysis, one 
concluded that glue did not provide any significant advantage 15, one concluded that there 
is insufficient evidence to promote fibrin sealant 16, two showed a reduction of CPIP 17,18, but 
one of these underlined the poor quality of the trials 19, and another study concluded that 
glue contributed to reduce postoperative pain and early chronic pain (3-6 months) but not 
late chronic pain 20.
To conclude, there is insufficient evidence to promote glue or self-gripping meshes rather 
than suture fixation during Lichtenstein hernioplasty. In addition, meta-analysis exploring 
other open mesh techniques using the Prolene Hernia system (PHS) or other mesh plugs 
have shown no difference in the rate of CPIP for the open mesh techniques.21,22 
The trials investigating the Progrip mesh assumed that CPIP is mainly caused by neuro-
pathic pain caused by mechanical entrapment of nerve fibers by devices used to secure 
the mesh, however entrapment can also be caused by the mesh itself and neuropathy is 
not only mechanically induced. Nerves can also be damaged during the dissection and 
diathermic heat. In addition there is a role for the immune system. The implanted mesh 
(and sutures) elicits an inflammatory and fibrotic response that imparts strength to the 
hernia repair, but on the other side may cause neuropathological effects in adjacent nerves. 
This immune response, also called the foreign body reaction (FBR), is highly dependent on 
mesh biocompatibility which is mainly determined by its material and structure. The Progrip 
mesh is a composited macroporous mesh made of standard monofilament polyester or 
polypropylene supplemented with resorbable polylactic acid (PLA) micro hooks. Since 
the Progrip mesh did not reduce CPIP rates an important question is whether the material 
characteristics or disintegration of the PLA micro hooks trigger possible inflammatory reac-
tions which negatively affect the occurrence of CPIP. In an experimental rat model by Kolbe 
et al, no increased tissue reaction could be determined in comparison with conventional 
polypropylene. 23 Studies in humans are not available. Since macrophages play an important 
role in directing the intensity and balance of the host immune response we analyzed the 
macrophages reaction to the Progrip mesh in an in vitro model of human primary macro-
phages and determined the production of pro- and anti-inflammatory cytokines. (Chapter 
6). Macrophages seeded on the Progrip mesh produced a commensurate amount of both 
pro-inflammatory and anti-inflammatory/repair proteins compared to a pure polyester 
mesh reflected in the same M1/M2 index. It was concluded that the polylactic micro-hooks 
did not alter the acute response of the macrophages. Whether this also means compa-
rable inflammatory damage to tissues and nerves is not clear, because of the limitations 
in translating the results of the in vitro model to the in vivo situation. First it is a mono 
cellular evaluation not enchanting for all the other cells involved in the FBR. Thereafter the 
artificial circumstances eliminate surgical factors. Nevertheless the in vitro model will help 
to investigate whether some unwanted side effects as CPIP are likely to be due to the type 
of mesh implanted or that other factors might be more important.
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Of the surgical factors only the type of mesh fixation was changed in the HIPPO trial. 
The anterior approach to the inguinal hernia / orifice still encompassed dissection during 
which tissues and nerves can be damaged. The inguinal nerves run in the plane anteriorly 
to the transversalis fascia. Therefore some might wonder why to perform an open anterior 
approach at all. The laparoscopic posterior techniques have shown faster recovery times 
and lower CPIP risk.24,25 However this disregards the surgeons’ obligation to tailor treatment 
based on expertise, local/national resources, and patient and hernia related factors. For 
high-risk patients with extensive comorbidities or patients with pelvic scarring an open 
mesh repair (under local anesthesia) is still the preferred technique as is the case for recur-
rent inguinal hernia after laparoscopic repair according to the world guidelines for groin 
hernia management 2016.
Other surgical factors that may be of influence on CPIP are handling of the inguinal nerves 
and hernia sac, type of anesthesia, experience of the surgeon and postoperative complica-
tions. 4,26 Due to randomization these factors were evenly distributed among the two groups 
in de HIPPO trial (Chapter 4). Regarding the experience of the surgeon, it was suggested 
by Kingsnorth that the Progrip mesh would show its benefit especially in the hands of 
inexperienced surgeons less able to identify nerves and keeping them away from the mesh 
or accidentally suturing the periostal layer of the pubic bone.27 Although not proving, this 
suggestion was not confirmed by the results of the HIPPO trial in which most patients were 
operated by residents.
Besides surgical factors methodological factors have to be addressed when interpret-
ing the literature on CPP. The burden of CPP for a significant surgical patient population 
and global health care has driven many investigators to find adequate preventative mea-
sures relevant to surgical practice. One drawback of published CPIP literature is the lack 
of consensus regarding the definition of CPP and a golden standard research approach. 
Study methods and outcome measures differ highly between studies making it difficult 
to compare study results and to conduct meta-analysis and systematic reviews. Thereafter 
validity is sometimes questionable with studies lacking baseline measures, power calcula-
tions, lack of control groups to adjust for confounders, unblinded pain assessment by the 
study investigator itself, assessment of pain by telephone interviews or using unvalidated 
questionnaires, no definition of the primary outcome parameter, insufficient follow-up etc. 
However it is always easy to point out the mistakes of others. Sometimes a retrospective 
cohort study is just used to have a quick indication of a research question after which a 
formal RCT can be deployed. We did it the same way with the HIPPO trial. Furthermore the 
trials in this thesis also have their imperfections; we did not see all patients on the outpa-
tient clinic for follow-up, we did not perform quantitative sensory testing to analyze sensory 
dysfunction, we could have performed a more exhaustive evaluation of patient related risk 
factors for CPIP, there was no uniformity in the type of anesthesia and operating surgeons, 
we did allow the extra stitch in the HIPPO trial, we did not perform subgroup analysis….. 
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So clinical trials in their essence are hardly ever perfect and researchers learn by the way. 
However it would be helpful and beneficial for the quality and comparability of research 
to have a broad accepted and well defined disease specific uniform research strategy with 
pre-defined outcome measures, follow-up times and validated assessment tools.
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It is clear that CPP is common and may develop more or less after the whole spectrum of 
surgical treatments. Therefore it is important to accept that CPP can arise after surgery and 
to raise awareness amongst healthcare professionals and patients alike.1 Information on CPP 
has to be a component of informed consent for surgery. Some patients, if given accurate 
data about the risk of CPP, might decide against having operations that are not entirely 
necessary. Thereafter, CPP needs to be considered in the indications for surgery, especially 
in the case of inguinal hernia surgery and chronic abdominal pain since not cure but quality 
of life is the main outcome of it. The evaluation and advice of a dedicated anesthesiologist 
part of the hospitals pain team may add in this. Last, the awareness of CPP has to lead to 
more attention to intra- and post-operative pain management since the intensity of pain 
in the days and weeks after an operation is one of the strongest and most consistent risk 
factors for CPP. The approach of so-called “preventive or preemptive analgesia” by the use of 
pre-operative local anesthesia has to become common practice.2-4.
As CPP is notoriously difficult to treat it is desirable to prevent its development. Besides 
focusing on surgery related factors, patient related factors deserve the same attention or 
even more. It is known that some patients are more at risk to develop CPP than others. 
Hence it would be advantageous to have a pre-operative patient specific risk model for the 
occurrence of CPP. This risk model may contain 
1) General patient related risk factors
2) Results of Quantitative Sensory Testing (QST); a systematic review of predictive experi-
mental pain studies of QST has already shown that the preoperative pain response to a 
nociceptive stimulus correlates with the intensity of early postoperative pain. This is not 
very accurate yet so further fine tuning is required.
3) Genotyping; there seems to be a genetic susceptibility for CPP. Identification of certain 
‘pain genes and enzymes’ like the COMT genes, GTP hydroxylase and DQB1*03:02 HLA 
haplotype are already promising. 5.
Preoperative psychometric evaluations of vulnerability, anxiety, depression and pain cata-
strophizing have shown to be less predictive.6 
In patients that turned out to be at very high risk for CPP the medical indication for surgery 
has to be called into question.
Regarding surgical factors during hernia surgery, it would be helpful to get more insight 
in the clinical and personal surgical performance. A national or (preferably) international 
registry of inguinal hernia patients can add in this. Good examples are the EuraHS and the 
Danish Hernia Registry or a national registry within the Dutch Institute for Clinical Audit-
ing. These registries can also be used to answer various research questions that require 
large patient cohorts. It is of utmost important that everyone is willing to participate in 
the registry, that data are inputted correctly and completely. Registration will also facilitate 
more uniform operative notes that record all steps that may be involved in the occurrence 
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of postoperative pain. This will also help surgeons and residents to pay attention to these 
important steps in inguinal hernia surgery.
Another problem is that many modifications of the Lichtenstein technique are practiced 
and compliance among surgeons and residents with Amid’s guidelines is variable. 7 8 This 
may be a lack of unawareness, skepticism or inadequate anatomical knowledge. Since resi-
dents learn the technique from their supervising senior residents and surgeons there is a risk 
of inconsistencies to sustain. Regarding the complexity of inguinal hernia surgery, especially 
with regard to a three nerve-sparing approach, outcomes may be improved when inguinal 
hernia surgery is only performed and taught by certified abdominal wall hernia surgeons 
as is the case for all other surgical treatments. They should be familiar with the repair 
techniques, anatomy, especially the most common inguinal nerve distribution patterns and 
variants, mesh related issues, risk factors for CPIP and local anesthesia techniques. Only in 
that case surgical patient specific “fine tuning” would be possible.
Thereafter a revision of residents training should be considered. A survey among Dutch 
residents (presented at the World Congress on Hernia Surgery 2016) revealed that most 
residents start with inguinal hernia surgery before a full understanding of the anatomy and 
with limited laparoscopic skills. This is not an efficient way of learning.9 Since case numbers 
can no longer be guaranteed in the operation room and society no longer accepts morbid-
ity that is associated with trainee errors, residents better prepare themselves outside the 
OR 10. This will also enable them to focus on more complex issues inside the operating 
room and take the maximal teaching experience out of the exposure in the OR. Outside 
training programs are already part of the training of surgical trainees, but inguinal hernia 
surgery is under represented and / or scheduled too late in the curriculum. Thereafter most 
still focus on the open procedures and hands on inguinal hernia courses are not a regular 
part of the program. Resources such as the Surgical Council on Resident Education (SCORE 
) may help to enhance common knowledge. In addition simulation enables residents to 
practice manual dexterity and their knowledge of the anatomy and different steps of repair 
techniques and would be a perfect preparation or warming up for OR experience especially 
when used in a distributed manner.11
CPIP and CPP literature will benefit from a common standard formulated by an inter-
national collaboration of dedicated abdominal wall hernia surgeons like the Hernia Surge 
Group. This common standard should contain a clear definition of CPIP. Considering the 
effect of CPIP on daily life this definition has to include not only a measure of time and 
pain intensity but also a description of pain-related impairment. Other elements which 
may be part of this common standard are a description of the ideal study methodology. 
This may enhance the comparability and quality of studies. Items to be included are at 
least 1) baseline scoring of pre-operative pain, QOL and risk factors for CPIP, 2) well-defined 
standard outcome parameters, 3) detailed assessment of the location, characteristics, and 
evolution of painful symptoms and associated changes in neurologic function, 4) follow-up 
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by independent assessors on standardized time points during at least 2 year, 5) standard 
validated measurement tools, 6) uniform nerve management. Regarding point 5 an easy 
to use, hernia-specific tool incorporating assessment of both PI and QOL is strongly recom-
mended. Good examples are the Inguinal Pain Questionnaire and the Caroline Comfort 
Scale. However, without an ambitious implementation plan designed to reach targeted 
groups, the impact of a common standard could be disappointing. Global recognition and 
awareness is essential and may be accomplished through the world wide hernia societies.
Finally, CPP is expressed against a complex physiological, genetic, and psychosocial 
background, which contributes not only to the conversion of somatosensory activity into a 
pain experience, but also to the amplitude of a reaction to the pain sensation and to related 
changes to mood and behavior. The complex way in which these factors interplay with each 
other needs a multidisciplinary pre- and post-operative approach directed by the (hernia) 
surgeon in narrow collaboration with an anesthesiologists dedicated to CPP and able to 
address the psychosocial factors involved in CPP.
To conclude, due the multifactorial etiology of CPP it is virtually impossible to isolate a 
single causative factor responsible in the development of CPP. Only a multipronged ap-
proach can provide a strong tool to reduce the impact of CPP. Prevention still remains the 
panacea to CPP.
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Introductie
A
INTRODUCTIE 
Chronische postoperatieve pijn (CPP) is een veelvoorkomende complicatie na openbuik 
operaties of liesbreukoperaties. Dit leidt bij patiënten tot een verminderde kwaliteit van 
leven en mede door de prevalente aard van deze ingrepen ook tot economische gevolgen 
doordat mensen meer gezondheidszorg consumeren en soms niet in staat zijn om te 
werken. Tot wel 50% van de patiënten ervaart chronische pijn na operaties waarvan 5% 
ernstige pijn heeft. In de introductie van dit proefschrift (hoofdstuk 1) wordt een overzicht 
gegeven van de definitie, pathofysiologie en behandeling van CPP. De precieze oorzaak van 
CPP is niet geheel duidelijk, maar bekend is dat zowel patiënt gebonden als operatie gere-
lateerde factoren een rol spelen Risicofactoren zijn onder andere het hebben van ernstige 
pijn gedurende meer dan een maand voor de operatie, psychologische kwetsbaarheid, het 
vrouwelijke geslacht, jonge leeftijd, maar ook genetische factoren. Op het chirurgische vlak 
zijn de chirurgische techniek, benadering en duur van de operatie als risicofactor geïden-
tificeerd. Pijn kan worden onder verdeeld in weefselpijn (nociceptieve pijn) en zenuwpijn 
(neuropatische pijn). Nociceptieve pijn ontstaat ten gevolge van weefselbeschadiging (zo-
als bij een operatie) of ontsteking. Neuropatische pijn ontstaat door de beschading van een 
zenuw welke vervolgens pijnsignalen blijft afgeven naar de hersenen. Bij neuropatische pijn 
is men nooit zonder pijn, omdat de zenuwbeschadiging niet weg gaat. Zenuwpijn is vaak 
scherp van aard alsof er met naalden geprikt wordt of kan lijken op een elektriciteit schok.
DEEl 1 CHRONISCHE PIJN NA bUIK OPERATIES: HET NUT VAN ADHESIOlYSE
In het eerste deel van dit proefschrift wordt ingegaan op chronische pijn ten gevolge van 
littekenweefsel, adhesies, ontstaan na een open buik operatie.
In hoofdstuk 2 worden de lange termijn resultaten beschreven van een placebo ge-
controleerd onderzoek naar het nut van laparoscopische adhesiolyse (het doornemen van 
adhesies tijdens een kijkoperatie) bij patiënten met buikpijn toegeschreven aan postopera-
tieve adhesies. Na 12 jaar bleken de patiënten die behandeld waren met laparoscopische 
adhesiolyse significant vaker nog pijn te hebben (RR=1.30), meer pijnstillers te gebruiken 
(RR=1.20), vaker een medisch specialist te consulteren (RR=1.33) en vaker opnieuw te zijn 
geopereerd (RR=1.20) vanwege persisterende buikpijn in vergelijking met patiënten die 
alleen een kijkoperatie hadden ondergaan zonder aanvullende adhesiolyse. Er wordt dan 
ook geconcludeerd dat laparoscopische adhesiolyse niet zinvol is in de behandeling van 
chronische buikpijn op basis van adhesies maar ook dat een kijkoperatie een langdurig 
placebo effect kan hebben. Aangezien adhesiolyse gepaard kan gaan met chirurgische 
complicaties wordt geadviseerd deze behandeling te mijden.
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DEEl 2 CHRONISCHE PIJN NA lIESbREUK HERSTEl: EEN ZElF KlEVENDE MAT
In het tweede deel van dit proefschrift worden de effecten op chronische post operatieve 
pijn van een zelf klevende mat voor het herstel van een liesbreuk bij volwassen patiënten 
beschreven. Het herstel van de liesbreuk gaat volgens de Lichtenstein plastiek, een van 
de meest gebruikte technieken om een liesbreuk te herstellen. Bij de Lichtenstein plastiek 
wordt de breukpoort in de lies afgedicht door aan de voorzijde van de buikwand een mat 
te plaatsen over deze breukpoort heen. Hierna wordt de mat gefixeerd met niet oplosbare 
hechtingen.
Hoofdstuk 3 beschrijft de vijf jaar resultaten van een cohort van 83 patiënten die als 
pilotstudie gebruikt zijn voor de HIPPO trial (Hoofdstuk 4). De hypothese was dat het ge-
bruik van een zelf klevende mat voor het herstel van een liesbreuk volgens de Lichtenstein 
plastiek minder post operatieve pijn geeft in vergelijking met een mat die wordt gefixeerd 
met hechtingen. Chronische post-operatieve inguinale pijn (CPIP) was gedefinieerd als elke 
VAS (pijn) score groter dan 0, die drie maanden na de operatie nog aanwezig was. Na een 
follow-up van 30 maanden meldde 14.6% van de patiënten in de groep met de zelfklevende 
mat (n=41) CPIP ten opzichte van 23.8% van de patiënten in de standaard Lichtenstein plas-
tiek groep (n=42). Na een follow-up van 67 maanden was de incidentie van CPIP gedaald 
naar 4.8% respectievelijk 9.8%. CPIP was van invloed op de dagelijkse kwaliteit van leven 
in 2.4% respectievelijk 7.1% van de patiënten na 30 maanden en 0% respectievelijk 2.4% 
na 67 maan-den. Ernstige pijn (VAS>70) werd alleen gezien in de standaard Lichtenstein 
groep. Het recidief percentage was 4.8% voor de zelf klevende mat en 2.4% voor de stan-
daard mat. De operatietijd was significant korter voor de zelfklevende mat. Deze resultaten 
waren de basis voor het starten van de de HIPPO trial, die beschreven is in Hoofdstuk 4. 
Dit dubbel blinde gerandomiseerde onderzoek vergelijkt een zelf klevende mat met een 
mat gefixeerd met niet oplosbare hechtingen voor het herstel van een liesbreuk volgens de 
Lichtenstein plastiek. De resultaten zijn gebaseerd op een groep van 331 patiënten die 2 jaar 
lang gevolgd zijn. De zelf klevende mat had een vergelijkbare incidentie van CPIP, recidief 
hernia en andere post-operatieve complicaties als de gehechte mat. De incidentie van CPIP 
na 24 maanden was 4,6% voor de gehele groep. Het recidief percentage was 2.4% voor 
de zelfklevende mat en 1.8% voor de gehechte mat. De operatietijd was significant (17%) 
korter voor de groep waarbij de zelfkle-vende mat gebruikt werd.
In hoofdstuk 5 zijn de lange termijn resultaten van de zelf klevende mat verder onder-
zocht middels een systematische review van de literatuur waarna een meta-analyse van 
10 gerandomiseerde onderzoeken met in totaal 2541 patiënten is verricht. De gemiddelde 
follow up was 24 maanden (varierend tussen 6-72 maanden). Uit de analyse kon worden 
geconcludeerd dat de zelf klevende mat geen oplossing biedt voor het ontstaan van CPIP. 
De incidentie van CPIP, recidief hernia en andere lange termijn morbiditeit was vergelijkbaar 
voor beide matten. Echter hierbij moet wel worden opgemerkt dat conclusies nog altijd 
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gebaseerd zijn op relatief korte follow-up en kleine aantallen patiënten ten gevolge van 
heterogeniteit in de definitie en meting van CPIP en de wijze waarop uitkomsten worden 
weergegeven. Het belangrijkste voordeel van de zelf klevende mat is zijn efficiëntie hetgeen 
leidt tot een significante verkorting van de operatietijd.
Hoofdstuk 6 presenteert de resultaten van een in vivo studie naar de reactie van 
macrofagen op de polymelkzuur haakjes aan de onderzijde van de zelfklevende mat. De 
reactie van macrofagen en de productie van pro- en anti-inflammatoire cytokinen was 
vergelijkbaar voor de zelf klevende mat en een standaard polypropyleen mat zonder de 
polymelkzuur haakjes. De polymelkzuur haakjes lijken dus geen negatieve invloed te heb-
ben op de biocompatibiliteit van de mat.
DEEl 3 CHRONISCHE PIJN: DE bEOORDElING
In deel drie wordt in gegaan op de kwaliteit en uniformiteit van de literatuur betreffende 
chronische pijn na liesbreuk operaties.
Hoofdstuk 7 vermeldt de resultaten van een systematisch literatuur onderzoek naar de 
kwaliteit en uniformiteit van onderzoeken naar CPIP. In het systematische onderzoek werden 
80 studies geïncludeerd. Slechts de helft hiervan vermeldde een definitie van de primaire 
uitkomstmaat CPIP. In totaal werden 22 verschillende definities geïdentificeerd waarvan de 
definitie van de Internationale organisatie voor de studie naar pijn (IASP) de meest gebruikte 
definitie was. In 66% van de studies werd gebruik gemaakt van een gevalideerde vragenlijst 
om de aanwezigheid van CPIP te evalueren en er werden 33 verschillende vragenlijsten 
geïdentificeerd. De visual analogue scale (VAS) en de Short Form 36 (SF36) waren de meest 
gebruikte gevalideerde vragenlijsten voor het meten van pijn intensiteit en de kwaliteit van 
leven. Bij het onderzoeken van chronische pijn is het belangrijk om niet alleen de kwantiteit 
van de pijn te meten maar om ook de effecten ervan op het dagelijks leven te meten. Dit 
werd gedaan door slechts 40% van de studies. Een 0 meting werd verricht in 45% van de 
studies en 75% vervolgde de patiënten tenminste 12 maanden.
Er werd geconcludeerd dat de huidige literatuur naar CPIP na herstel van een liesbreuk 
zeer varieert in kwaliteit en er een gebrek is aan uniformiteit. Dit bemoeilijkt een goede 
vergelijking tussen de uitkomsten van de studies en daarmee het maken van breed gefun-
deerde aanbevelingen voor de preventie van CPIP.
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copromotor wilt zijn!
Prof. dr. H van Goor, beste Harry. Dingeman Swank was het die ons in contact bracht 
voor een eventuele QST meting in de HIPPO trial. Logistiek gezien was deze toevoeging 
helaas niet haalbaar. Later wisselden we in New York nog ideeën uit over het samenvoegen 
van onze databases over adhesiolyse. De echte samenwerking kwam uiteindelijk op een 
ander vlak tot stand, namelijk de practica van de bootcamp, de introductieweek voor de 
eerste jaar AIOS van de ‘common trunk’, samen met Otmar Buyne. Niet alleen leerzaam en 
inspirerend voor de jonge aios, maar zeker ook voor de begeleiders! Zeer inspirerend en een 
eye opener was het om deel te nemen aan uw sessie over educatie binnen de Heelkunde 
op het World Hernia Congres in Milaan. Heel erg bedankt voor deze inspirerende kijkjes in 
de toekomst! Het is een ware eer dat u plaats heeft willen nemen in de leescommissie en ik 
wil u daar zeer voor bedanken.
Prof. dr. F. Huygen. Een anesthesist gespecialiseerd in pijn kan natuurlijk niet ontbreken. 
In het allereerste begin heeft u me op weg geholpen met de pijn vragenlijsten voor in de 
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HIPPO trial. Ik ben benieuwd of het uiteindelijke resultaat van mijn boekje ook uw goedkeur-
ing krijgt. Bedankt voor de hulp en uw deelname in mijn promotiecommissie.
Prof.dr. G.J.Kleinrensink, beste Gert-Jan. Uw anatomie practica zijn vermaard! Eindelijk 
begreep ik de anatomie tijdens de TEPP. Bedankt voor al deze leerzame momenten. Uw 
enorme enthousiasme voor het vak neem ik als voorbeeld met me mee. Heel erg bedankt 
voor uw deelname in mijn promotiecommissie.
Prof.dr. de Ridder, beste Victor. U was het die mij belde op een middag ruim 6 jaar 
geleden. Er waren wat vragen gerezen nadat u mijn artikel over de pilotstudie ter review 
had gekregen. Kritische en nieuwsgierige vragen. Leuk. Wie had toen gedacht dat even later 
het vervolg van de pilotstudie, de HIPPO trial, ook in uw kliniek zou plaatsvinden. Bedankt 
voor deze mogelijkheid. Een mooie afsluiting dat u nu als hoogleraar plaats heeft willen 
nemen in mijn promotiecommissie. 
De statistici: Dr.ir. W.C.J. Hop. U was de eerste waar ik op advies van Dingeman Swank 
aanklopte. Helaas net voor uw pensioen. Nieuwe projecten werden niet meer aangenomen, 
maar u was wel zo behulpzaam om wat beginnersfoutjes uit mijn studieprotocol te halen. 
Ontzettend bedankt daarvoor! Bart Torensma, jij nam vanaf nu alle statistiek van Dingeman 
en consorten voor je rekening. Er was direct een klik en dat maakte de statistiek wat minder 
saai. Zo enthousiast al jij met cijfers aan de slag ging… je was de redder in nood. Ondank je 
eigen drukke schema met promoveren, opleiding, eigen bedrijf. Heel erg bedankt dat je tijd 
voor me vrij maakte, voor al je hulp en goede gesprekken! 
REPAIR onderzoeksgroep, zoals gezegd had ik meer tijd met jullie door willen brengen. 
Jullie waren een enthousiaste, inspirerende groep waar ik me altijd zeer welkom voelde als 
ik weer eens aan kwam schuiven.
Dr Philipe Chastan, de pionier op het gebied van de Progrip mat. Bedankt dat u uit 
Frankrijk over heeft willen komen om uw expertise met ons te delen tijdens een masterclass 
in het Groene Hart Ziekenhuis. Merci beaucoup!
Anneke van Duuren, ontzettend bedankt voor het verwerken van die tientallen mappen 
vol data in keurige databases. Ongelooflijk fijn dat je dat zo netjes en snel voor elkaar kreeg. 
Heel erg bedankt daarvoor! 
Mede auteurs, Brechtje Grotenhuis, Bart Torensma, Chris Lange, Johan Lange, Arthur 
Wijsmuller, Ruth Kaufman, Nienke Grotenhuis. Jullie hebben ontzettend veel werk verricht. 
Zonder jullie was dit proefschrift er niet geweest. Mijn dank is groot.
Saïd Askar, weliswaar geen mede auteur, maar wel van onschatbare waarde geweest op 
het mo-ment dat ik het met mijn review niet meer zag zitten. Bedankt voor je kritisch blik en 
restylen van het artikel. Met succes! 
Groene Hart Ziekenhuis. Allereerst de maatschap chirurgie. Mijn eerste kennismaking 
bij de Heel-kunde was bij jullie in het Groene Hart Ziekenhuis. Het heeft een ommekeer 
veroorzaakt. Was ik er nog heilig van overtuigd internist te willen worden, na het co-schap 
Heelkunde was dat snel en zeker over. Hierna heb ik nog heel wat jaren bij jullie door mogen 
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groeien. Het voelde als een warm bad. Heel erg bedankt voor al jullie support en alles wat 
ik van jullie heb mogen leren op chirurgisch, wetenschappelijk en persoonlijk vlak. En zeker 
ook bedankt voor de gezelligheid! Deze mooie tijd was natuurlijk lang niet zo mooi geweest 
zonder de hechte assistenten groep. Dorien, Wendy, Xander, Toni, Kim, Sytse, Ties, Mireille, 
Vera, Roderick, Lotte, Anne, Alexander, Chris, Coen, Davut, Pieter, Johannes. Heel erg bedankt 
voor de samenwerking en gezelligheid! Het waren geweldige jaren!
Sint Franciscus Ziekenhuis. Bedankt dat mijn HIPPO trial bij jullie heeft mogen lopen. 
Jullie hebben ontzettend veel patiënten geïncludeerd waarvoor veel dank. Brechtje als 
kartrekker, je had het fantastisch voor elkaar. Alles altijd keurig op orde en bereid te helpen. 
Het was een fijne samenwerking.
Verder wil ik iedereen bedanken die betrokken is geweest bij de uitvoering van de 
multicenter HIP-PO trial: allereerst de patiënten. Zonder de bereidheid van patiënten om 
deel te nemen aan onderzoek zou de wetenschap het een stuk lastiger hebben. Toch is het 
niet niks om tijd vrij te maken voor extra beoordelingen op de polikliniek en invullen van 
vragenlijsten. En het kan ook best spannend zijn om deel te nemen aan onderzoek, zeker 
als de uitkomst niet zeker is. Mijn dank is zeer groot! En dit geldt ook voor de lokale coör-
dinatoren, dames van het opnamebureau, inkoop van de OK, operatie verpleegkundigen, 
verpleegkundigen op de polikliniek, de mensen van de postkamer, Wendy Plokkaar van 
het secretariaat Heelkunde en de assistenten en chirurgen van het Groene Hart en Sint 
Franciscus Ziekenhuis.
De hernia chirurgen, Roderick Schmitz (Groene Hart zh), Andrzej Baranski (LUMC), Lieke 
Welling (LUMC), Erwin van Geffen (Jeroen Bosch zh), jullie hebben mij, allen op jullie geheel 
eigen wijze, de tips and tricks van de hernia chirurgie geleerd. Heel erg bedankt daarvoor!
Opleiders, Roderick Schmitz (Groene Hart zh), Jaap Hamming (LUMC), Koop Bosscha 
(Jeroen Bosch zh), heel erg bedankt voor al jullie support en vertrouwen. Jullie stonden 
altijd klaar, hadden de opleiding in de breedste zin van het woord op de eerste plaats staan, 
dus ook ruimte voor persoonlijke en wetenschappelijke ontplooiing. Heel erg bedankt dat 
jullie dit allemaal mogelijk gemaakt hebben en bedankt voor alle wijze raad.
Lieve Mam, broer en zus, jullie hebben altijd in mij geloofd en voor mij klaar gestaan. 
Met name de HIPPO trial was een hele klus en zonder jullie hulp was het niet gelukt. Zus 
super bedankt voor het vouwen van stapels patiënt formulieren en enveloppen tijdens 
je zwangerschapsverlof. Martijn ongelooflijk zo handig als jij bent met ICT en websites. Ik 
had mij geen mooiere trial website kunnen voorstellen. Bedankt! Mam jij hebt heel wat 
patiënten na gebeld om de follow up voor elkaar te krijgen. Van onschatbare waarde was 
en is uw steun, vertrouwen en liefde. Ik hou van jullie. En ik mis pappa. Zo veel te vroeg is 
hij van ons weg gegaan. Hopelijk krijgt hij toch wat mee vanuit ‘zijn kamertje daarboven’. Ik 
probeer de laatste wijze raad die hij aan mij mee gaf waar te maken, de balans houden in 
het leven en beseffen dat er meer is dan werken, maar dat is niet altijd makkelijk als je op je 
vader lijkt en je je werk zo leuk vindt..
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Lieve Wouter, je bent het mooiste wat mij overkomen is. Je werd een fijne afleidende 
factor hetgeen mijn promotie goed heeft weten te vertragen, maar zonder jouw onvoor-
waardelijke steun, vertrouwen, adviezen, humor en liefde was het überhaupt niet gelukt. 
Nu jij nog. En daarna nog meer tijd om samen te genieten van de toekomst! Ik hou van je! 
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July 2012 - Okt-2017
Prof. Dr. Johan F. Lange
Prof. Dr. Johannes Jeekel
Prof. Dr. Gert-Jan Klein Rensink
Year ECTS
Courses 
- Precourse RICH congress 2010 1.0 
- Basic introduction course on SPSS 2012 1.0 
- BROK (‘Basiscursus Regelgeving Klinisch Onderzoek) 2012 1.5 
- Hernia course, Covidien, Hamburg 2013 1.0 
-  Laparoscopic component separation technique by Prof. Dr. Lars N. Jorgensen, 
Kopenhagen 
2016 1.0 
- Precourse European Hernia Congres, Wenen 2017 1.5 
Presentations
-  Regionale Wetenschapsdag Regio Leiden - ‘ De HIPPO trial: Hernia Inguinalis 
Parietex versus Parietex Progrip Onderzoek’  
2010 1.0 
- Assistentencarrousel Groene Hart Ziekenhuis- ‘ The femoral hernia’  2010 1.0 
-  Regionale Wetenschapsbespreking, LUMC - ‘The HIPPO trial, a randomized double 
blind trial comparing self-gripping Parietex Progrip Mesh and sutured Parietex 
Mesh in Lichtenstein hernioplasty; a long term follow-up study’ 
2012 1.0 
-  SEOHS, Amsterdam - ‘Less chronic pain after Lichtenstein hernioplasty using the 
self-gripping Parietene Progrip Mesh, a Pilotstudy’  
2012 1.0 
-  World Congress on Hernia Surgery, Milaan - ‘The Need to learn (hernia surgery)’  2015 1.0 
-  European Hernia Congres, Rotterdam - ‘The HIPPO trial, a randomized double blind 
trial comparing self-gripping Parietex Progrip Mesh and sutured Parietex Mesh in 
Lichtenstein hernioplasty; a long term follow-up study’  
2016 1.0 
- Wetenschapsdag Jeroen Bosch Ziekenhuis - ‘ The HIPPO trial’  2016 1.0 
-  European Hernia Congres, Wenen - ‘ Influence of polylacid acid supplementation 
on the biocompatibility of a polyester mesh for hernia repair using a in proved in 
vitro model’  
2017 1.0 
Conferences and seminars
- Regionale Wetenschapsbespreking, LUMC 2010 1.0  
- RICH: 6th Rotterdam Interactive Congress on Hernia 2010 1.0 
- SEOHS, Amsterdam 2012 1.0  
- 5th International Hernia Congress, New York 2012 1.0 
- World Congress on Hernia Surgery, Milaan 2015 1.0  
- European Hernia Congres, Rotterdam 2016 1.0 
- Wetenschapsdag Jeroen Bosch Ziekenhuis 2016 1.0  
- European Hernia Congres, Wenen 2017 1.0 
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- Chirurgendagen  2016-2017 6.0 
Teaching
- Klinisch les hernia’s, Groene Hart Ziekenhuis 2010 1.0 
-  Practicum introductie cursus eerste jaars assistenten Heelkunde, Orthopedie, 
Plastische chirurgie 
2014-2016 4.0 
Totaal 34
